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ABSTRACT
Ionizing radiation can have several different effects on cells, some are 
almost instantaneous such as the generation of DNA damage, other cellular 
responses take a matter of minutes or hours - DNA repair protein 
induction/activation, and others may take months or even years to be 
manifested - carcinogenesis.
Human epithelial cell lines derived from both normal, non-neoplastic 
tissues and from a malignant ‘source were cultured in order to examine 
several effects of ionizing radiation on such cell types. Cells not from a 
malignant source were previously immortalized by viral infection or by 
transfection with viral sequences.
Simian virus 40 immortalised uroepithelial cells (SV-HUC) were found to 
be approximately a factor of two fold more radioresistant than cells of 
malignant origin (T24) in terms of unrepaired clastogenic damage i.e. 
assessment of micronuclei levels following irradiation.
SV-HUC lines unlike T24 cells are non-tumourigenic when inoculated into 
nude a thymic mice. SV-HUC lines proved very resistant to full oncogenic 
transformation using radiation and chemical carcinogens. However, 
morphological alterations and decreased anchorage dependant growth was 
observed in post carcinogen treated cells after appropriate cell culture 
conditions were utilized. The progression from this phenotype to a fully 
tumourigenic one was not recorded in this study.
The ability of ionizing radiation to induce increased levels of the nuclear 
phosphoprotein p53 was also assessed using several different cell lines. SV- 
HUC and T24 cell lines failed to exhibit any increased p53 stabilization 
following irradiation. One cell line, a human papilloma virus transformed 
line (HPV) did show an approximate two fold increase of the wild type p53
i ii
protein after treatment with radiation. Only the cell line HPV showed any 
cell cycle delay, resulting in accumulation of cells in the G2 /M  compartment 
in post irradiation cell cycle analysis. The status of p53 was also assessed i.e. 
wild type or mutant conformation in all the above cells lines and two other 
control lines HOS (a human osteosarcoma cell line) and H Tori-3 (SV40 
immortalised thyroid epithelial cells).
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INTRO DUCTIO N
1.1 Human Carcinogenesis - Historical and Epidemiological Studies
Cancer has been described as a genetic disease at the somatic cell level 
(Bodmer 1988), occurring chiefly in cells of epithelial origin. Estimates place 
the proportion of adult human cancers arising in epithelial tissues at >90%
(Cairns 1975). This is not entirely surprising when the nature of such self - 
renewing epithelia is considered, a continual but usually controlled 
multiplication of dividing cells in basal layers replacing cells lost at the 
epithelial surface. It is this escape from normal cellular constraints and 
controlled growth initiated by somatic mutations, spontaneous or induced, 
that may be termed cancer.
The generation of human cancer due to physical and chemical 
environmental factors has been known for over a century; Marie Curie's |
death thought to be from leukaemia, due to her work with radium and 
Percival Pott's identification of scrotal cancer in children chimney sweeps due 
to their exposure to soot (1775). More recently there has been an expanding 
body of evidence implicating ionizing radiation exposure with increased rates 
of human cancer. Radium dial painters who ingested significant quantities 
of this a  emitter were often found to suffer from osteosarcomas in later life 
due to the incorporation of radium into bones since it lies in the same group 
of the periodic table as calcium. Atomic bomb attacks on Hiroshima and 
Nagasaki generated an excess of cancers in the surviving populations due to y 
and neutron exposure (Reviewed by Hall 1988). Within the last few years 
much controversy has been generated by the apparent increased rates of 
leukaemia and non-Hodgkin's lymphoma around nuclear reprocessing
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plants such as Sellafield in West Cumbria (Gardner et al., 1990). More |
accurately, there appear to be raised levels of leukaemia amongst the children 
of male workers exposed to occupational radiation prior to conception of 
these children.
However, many other varying factors such as diet, age, sex and genetic 
predisposition to cancer only serve to complicate the already limited data f
from such human in vivo studies. To gain a better understanding of the 
effects of radiation on mammalian and human cells it was necessary to turn 
to the use of cell culture and. in particular experiments using immortal cell 
lines.
1.2 The use of rodent cell lines to study neoplastic transformation in vitro.
The development of cell lines with an indefinite life span in culture which 
were not malignant in origin, enabled a great deal of investigation to be 
performed using defined conditions and closely controlled carcinogen #
exposures. Much of our present knowledge concerning a whole range of ÿ
radiation induced cellular changes is largely based on observations made in 
such cell lines.
The cell lines initially generated were derived from rodent fibroblast 
material which existed as primary cultures. However, after a careful regime 
of sub-culturing an immortal population of cells having survived "crisis" 
was generated (Reznikoff et ah, 1973a). Such cells required no further 
treatment to generate a population with an indefinite life span in culture.
Cell lines commonly used include; C3H 10TV2/ Balb/c - 3T3 and Chinese 
Hamster Ovary or CHO cells.
Soon after such cell lines were established it became possible, through 
treatments with chemical carcinogens and later radiation, to facilitate
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oncogenic or neoplastic transformation of such cells. That is to say, that cells 
maintained in culture generated dense type colonies (type II and III foci) on a 
confluent monolayer which when reintroduced into a mouse of the same 
strain as the initial parent cell type, generated tumours (Reznikoff et a l, 
1973b, Terzaghi and Little 1976). Also it became apparent that such cell lines 
were relatively easy to transform into an oncogenic phenotype from the non- 
tumourigenic parental phenotype. It is also worth noting the relatively 
simple treatment protocol used to generate such transformed foci when 
compared to the procedure used for human transformation work (see section 
1.3).
I
I
y
i
IÎi
24 hours 14 days
Plate cells
Treatment _____Radiation /Chemical Carcinogen
Approx 400 surviving cells
4 weeks
score dish for type n & in foci.
Cells not passaged into new dishes but simply medium changed.
FIG 1.1. Protocol for a cell transformation assay using C3H lOTVa cells. 
A duplicate series of plates were also treated in an identical manner but 
harvested after 14 days and the cell number determined. This enables 
transformation frequencies per surviving cell to be determined.
Taken from Hall and Hei 1986.
I
t:
Such cell lines are still extensively used to study the effects of a variety of 
different parameters on oncogenic transformation due to the highly 
reproducible results when standardised procedures are followed (Meeting 
Report 1985). Some of the more recent applications of such cell lines have
I.
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included the effects of particles of defined LET (linear energy transfer; Hei et |
al., 1988), restriction endonucleases (Bryant and Riches 1989) and cell cycle J
1dependence (Cao et aL, 1992, Miller et ai, 1992) on oncogenic transformation. ji
1.3. The use of human cell lines to study oncogenic transformation in 
vitro.
Despite the large amount of data generated concerning the responses of 
rodent fibroblast cell lines in transformation studies it remains unclear how 
accurately this relates to the human situation .
Firstly interspecies differences must be considered. Rodent cells exhibit a 
far higher degree of chromosomal instability than human cells do. Rodent 
cells acquire immortality and generate permanent cell lines spontaneously, 
human cells do not but instead need a foreign agent such as a virus to become 
immortal, i.e. cell crisis does not lead to the establishment of a cell line in \
human cell culture. Finally even when human cells have been immortalised 
they are often much more resistant to oncogenic transformation with either 
radiation or chemical carcinogens when compared to rodent cell lines 
(reviewed by Reznikoff et a l, 1986).
Cell type may also be another important factor when deciding on the 
suitability of model systems and their relevance to neoplastic development in 
humans. As mentioned earlier >90% of all human cancers originate in 
epithelial tissues, however all of the rodent cell lines discussed above are 
fibroblast in origin. Therefore a seemingly more suitable cell type to study 
would be one of human epithelial origin.
Initially only human cells that were from malignant sources could be 
cultured indefinitely since they were already immortal, but such cell lines are 
of no real significance when in vitro oncogenic transformation is being
INTRODUCTION
studied. With advances in cell culture methodology, more complex and 
defined media and the development of immortalisation techniques human
cells could now be maintained indefinitely in culture. Immortalisation of |
ihuman material usually relies on the infection of a primary tissue explant |
with a DNA tumour virus or at least a plasmid containing sequences from |
such a virus (Christian et al., 1987, Dipaolo et al., 1989, Thraves et al., 1990). 4
Human cells are nonpermissive for many such tumour viruses such as 4
Simian Virus 40 (SV40) i.e. they are not capable of permitting a lytic infection 
which generates more virus particles. However the early genes of this virus 
coding for the T-antigen protein, do integrate into the human cell’s DNA.
The production of this viral oncoprotein in the human cell leads to the |
generation of an immortal phenotype. This T-antigen of SV40 was reported 
to bind to a 53,000 Dalton protein (p53) in immortalised cells by Lane and 
Crawford (1979). The modification of function of p53 was found to be a vital 
switch able to transform a cell with limited life span in culture into an 
immortal one (the functions of p53 are considered more fully in Chapter 5).
Human papilloma virus although acting in a slightly different way since it 
can produce a lytic infection in human cells, also is able to immortalise cells 
since its E6 protein can abrogate p53 function (Lechner et al., 1992, Mietz et al.,
I1992). Cells immortalised by such methods are non-tumourigenic
(Christian et al,, 1987, Dipaolo et al., 1989, Thraves et al., 1990 plus see Chapter i|
4).
As with rodent cell lines full oncogenic transformation using chemical 
carcinogens was reported soon after such cell lines had been established |
(Reznikoff et al, 1988, Rhim et al., 1990, Bookand et al, 1992).
Tumourigenicity in such cases was checked for by tumour formation in 
athymic nude mice which have a deficient immune system and so allow
INTRODUCTION 7
growth of cells which are non-self. The cell culture procedure following 
carcinogen exposure differed considerably from that used to study rodent 
oncogenic transformation.
48 hours
Carcinogentreatment
7-14 days
Allow for recoveiy of surviving population
Plate cells out
FIG 1.2. Protocol for cell transformation 
assay using human cells. Again as with 
rodent work duplicate platings are 
performed in order to calculate 
transformation frequencies.
Taken from Reznikoff et ai, 1988.
Passage cells every time 
cultures are just 
subconfluent by replating 
Vsrd of the cells into a 
new culture container.
Continue topassage approx 5 times
Finally inoculate athymic mice, follow for upto 6 months and check for tumour formation.
Despite chemical carcinogen induced neoplastic transformation being 
achieved in such human epithelial cell lines, reports of radiation inducing a 
similar phenotype were not observed. The few exceptions to this were one 
isolated report of a human fibroblast being transformed by X-rays (Borek 1980) 
and the work carried out on human hybrid cells by Sun and Redpath. This
1.4a. Carcinogen interaction with DNA.
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hybrid cell line is the result of fusing a purported cervical carcinoma cell line 
(HeLa cells) and a normal skin fibroblast. Such cells are initially 
nontumourigenic but do readily undergo radiation induced oncogenic 
transformation after a treatment protocol similar to that used for the rodent 
transformation systems (Redpath et al, 1987, Sun et al., 1988, Redpath and 
Sun 1990). However, these cells must be considered "preneoplastic" and 
hence far less refractory to radiation induced transformation than their #
"normal" human counter parts. What this transformation system may in |
'■Afact be studying is the loss of a single tumour suppressor gene supplied by the
* yfibroblast cell, which is masking the previously expressed tumourigenic |
phenotype of the HeLa cell.
1.4. The multistep nature of carcinogenesis.
Cancer development is in most cases a prolonged, slow process by biological 
standards often lasting from one to two-thirds of the life span of the organism 
before it's manifestation (Farber and Rubin 1991). It is now widely 
acknowledged that cancer arises not from a single event within a cell, but via 
a multistep mechanism requiring the co-operation of a number of different 
cellular processes (Faber 1984). The only exceptions to this are the rapidly Sj
generated tumours formed as a result of oncogene containing retroviral 
infections (Benchimol 1992). Environmental exposure to biological, chemical I
& physical agents and genetic predisposition all serve to determine an 
individuals susceptibility to cancer. However, a series of common if not 
entirely universal cellular alterations in rodent and human, in vivo and in 
vitro systems has so far been elucidated:-
:
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Any potential carcinogen must ultimately interact with DNA and cause 
mutations that are then fixed in the surviving cell population. With 
radiation acting as the carcinogen it is absorbed by the nucleus within 10*15 
seconds and the damaging chemical processes involving free radical reactions 
are over within 10*5 seconds, i.e. it's effect on DNA is very rapid (Hall 1988).
Chemical carcinogens on the other hand are often metabolised by cells before 
their carcinogenic effects are exercised by such enzyme complexes as 
cytochrome P-450 and N-acetyltransferase (Harris 1991, Swaminathan and 
Reznikoff 1992). Such processes often have a genetic component associated 
with them and polymorphism of detoxifying enzymes is not uncommon 
between different individuals. Mechanisms such as these serve to regulate 
the rate and quantity with which DNA adducts are formed. (A more detailed 
description of the types of DNA adducts generated by the different carcinogens 
used in this study is given in section 4.8).
Several other species which are not enzyme complexes can also help to û
modify the extent of DNA adduct formation. Glutathione and other 
sulfhydryl containing compounds have a known mechanism of action acting 
as efficient scavengers of free radicals so exhibiting radioprotection 
properties. Recently a range of other, less likely candidates has been identified 
such as vitamin C, vitamin E, p-carotene and selenium which are dietary 
constituents that appear to act by limiting the extent of free radical reactions 
with DNA and so reduce the extent of possible oncogenic damage (von 
Sonntag 1987, Henderson et a l, 1991).
1.4b. DNA repair.
Once DNA damage has occurred whether it be deletion, base 
substitution/alteration, chain rupture etc... spontaneous or induced, the fate
INTRODUCTION 10
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of such a cell is now dependant on the repair processes that can be brought to 
bear in an attempt to rectify such damage. Cells containing damaged DNA in 
a vital coding region, i.e. one which codes for an essential protein or a control 
element such as a promoter or enhancer region for such a gene, now have 
three possible alternatives.
1. Successful repair of the damaged sequence - no phenotypic effect.
2. Non-repair or misrepair of the damaged sequence - cell death.
3. Non-repair or misrepair of the damaged sequence - cell death does not 
result but the damage is now fixed as a mutation, this may then contribute # 
towards carcinogenesis.
A full overview of DNA repair mechanisms is outside the scope of this 
thesis but it should be noted that mammalian cells like simpler prokaryotic |
organisms, appear to have a number of different types of repair processes. ^
These often complex processes requiring recognition, incision, excision and 
re-synthesis procedures can be engaged to deal with differing extents of 
damage as well as DNA damage of different types. These include; short-patch 
repair capable of operating on the major damage products of ionizing 
radiation and alkylating agents, long-patch repair which operates in response 
to UV like damage and "inducible or adaptive" repair in response to 
pretreatments of a carcinogen prior to a larger "challenge" dose (Hanawalt et 
al., 1979, Morimoto et al., 1986, Teoule 1987).
1.4c. Unrepaired DNA damage.
Unrepaired DNA lesions may be expressed in a number of different ways 
following genetic injury.
1. Cytogenetic damage. The generation of acentric fragments which no 
longer associate with other intact DNA at mitosis and nuclear division is one
4:^
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manifestation of such damage, these include chromosome & chromatid 
aberrations and micronuclei. Although DNA damage which is expressed in 
this form is often not as carcinogenic as say base substitutions, since the cell 
usually cannot cope with a large loss in genetic material and so such losses are 
lethal to the cell. Cytogenetic aberrations of this nature do serve to provide 
an indication of the extent of certain types of unrepaired genetic damage, 
screening for such aberrations often forms the basis of risk assessment 
following radiation exposure. Recently Kadhim et al (1992) have 
demonstrated that exposure of human cells to a irradiation can result in the 
transmission of chromosomal instability to daughter cell progeny several cell 
divisions later. This finding may have important implications for radiation 
induced leukaemia (see section 1.1).
2. Alteration of proto-oncogene function. There are now more than 30 
oncogenes that are known to participate in human cancer formation (Busch 
1990). Proto-oncogenes are cellular genes which code for proteins that control 
cell proliferation and differentiation within the cell (Wynford-Thomas 1991). 
Mutation within such a gene or misexpression (usually acting in dominant 
fashion) can lead to the generation of a neoplastic phenotype. They may be 
activated by a single point mutation such as the Ha-ras oncogene where a 
single base pair alteration at codon 12 leads to the substitution of a different 
amino acid in place of the usually present glycine (Tabin et ah, 1982, Balmain 
et ah, 1984). Alternatively they may be activated not by a structural alteration 
in the protein which is coded for by the oncogene but modified expression. A 
now well known example of this is the over expression of the c-tnyc 
oncogene usually located on chromosome 8q. However, when this oncogene 
is juxtaposed next to the Ig H region of chromosome 14q by a reciprocal
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translocation Burkitt’s lymphoma results. This is thought to result from the 
Ig H enhancer region increasing expression of c-myc (Klein and Klein 1987).
Oncogenes may be broadly split into three different groups depending on 
their site and mode of action.
a. An altered growth factor receptor molecule located on the plasma 
membrane. Example; c-erb B2 codes for a truncated epidermal growth factor 
receptor molecule that leads to constitutive tyrosine kinase activity (Wright et 
al., 1989, Arronson 1991).
b. Modification of signal transduction proteins which link growth 
factor/ growth factor receptor molecule binding to the generation of an 
intracellular signal such as increases in inositol triphosphate, diacylglycerol 
and Ca2+ by regulation of adenylate cyclase. Example; Ha-ras codes for a 
protein which shares a large degree of homology with G proteins. Mutation of 
the Ha-ras oncogene results in the subsequent 21 KDa or p21 protein being 
irreversible bound to GTP (guanosine triphosphate) and hence in a constantly 
active state (Levinson 1987).
c. Nuclear oncogenes. Modification of proteins which in turn alter the 
nuclear transcription rates of other genes. Example; fos oncogene which 4 
codes for a protein that controls the induction of immediate early genes 
regulating Gq -> Gi transition and subsequent progression through the cell 
cycle (Verma 1987).
Hence a cell containing activated oncogenes may acquire growth autonomy i
and no longer be dependent on extracellular mitogenic stimuli to induce cell 
division and growth.
3. Tumour suppressor gene inactivation. If oncogenes act by gain of function 
mutations behaving in a dominant fashion, then tumour suppressor genes 
can be said to act by a loss of function behaving in a recessive manner. j
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Initially tumour suppressor genes were often observed to be absent or in a I
homozygous mutant conformation in tumour cells. Tumour suppressor 
genes may be characterised by the following definition: "a genetic element |
whose loss or inactivation allows a cell to display one or another phenotype 
of neoplastic growth deregulation" (Weinberg 1991). At the biochemical level i
they appear to act as transducers of negative cellular proliferation signals i.e. 
down regulation of cell growth (Levine 1990, Lane 1992, Hartwell 1992).
Oncogenes do not normally show a familial inheritance since their gain of 
function acting in a dominant way is enough to cause sufficient abnormal 
embryonic development that lethality results, hence they are not found as 
germ line mutations. Alternatively tumour suppressor genes may be present 
as germ line mutations that are capable of transmitting to subsequent 
generations an increased susceptibility of neoplasia since they act in a 
recessive manner. This allows heterozygous individuals to develop 
normally and to sometimes reach reproductive maturity. Most known |
tumour suppressor genes have now also been found in association with 
genetically inheritable traits that increase an individuals risk of cancer.
Examples: The retinoblastoma gene (RB) located on chromosome 13ql4 is 
found in a disease sharing the same name which generates neoplasia of the 
retina. In the familial form of the disease a mutant RB allele is passed on 
from a genetically affected parent or else is generated at gametogenesis. In 
the sporadic form of the disease the mutant allele is generated after 
conception (Levine 1990). Wilms tumour, typified by familial kidney 
neoplasia, shares a striking similarity to the retinoblastoma story except the 
gene in this case is located on chromosome llp l3 . The p53 gene located on 
chromosome 17pl3.1 has also been found to be involved in a familial disease 
called Li-Fraumeni syndrome. The behaviour of this commonly found
4
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tumour suppressor gene is not strictly recessive nor dominant, but acts in a 
"dominant negative" fashion (Oren 1992, see section 5.2).
This recently discovered class of genes which appears to play a very central 
role in neoplasia, should in the near future, provide many further insights 
concerning the pathways and mechanisms used by cells in the development i
of cancer.
I
l,4d. Initiation, clonal expansion and promotion,
A single mutation on its own may not be capable of generating a neoplastic 
phenotype, but if the mutant cell has gained a selective advantage over other |
non-mutant cells eg. an increased growth rate, then this cell forms an 
increasing sub-population which can serve as a pool for secondary oncogenic 
alterations, i.e. clonal expansion.
There still remains considerable uncertainty as to the nature of the 
initiating step(s) in carcinogenesis. Experiments performed with C3H lOTl/2 
cells by Reznikoff et al. (1973b) and Kennedy et al. (1980) indicated that for |
both chemical and radiation induced neoplastic transformation, the 4
transformation frequency for type II and III foci was inversely proportional to 
the number of cells plated if the number of cells exceeded approximately 400 
cells per 100mm dish. Also, if a culture of lOTl/2 cells was allowed to recover 
following irradiation, split and replated at different cell densities, then the 
number of transformed colonies observed per dish remained constant. From 
this it was concluded that most if not all cells originally exposed to the 
carcinogen had become "initiated/altered" in some way and capable of 
transmitting to subsequent daughter cells an increased risk of transformation.
This also led to speculation that this initial heritable change was perhaps not 
genetic after all, or that mutation in any one of a large number of genes could
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produce an initiated state. Further support of this was indicated by the 
observation that protease inhibitors, which should have no effect on existing 
mutations, reverted initiated cells to their original uninitiated state (Kennedy 
1985). Although evidence such as this concerning the nature of initiation 
events may tend to question the validity of genetic involvement in oncogenic 
transformation, it is also worth noting that such data has been generated 
using just rodent systems which are easily transformed. The situation in 
human cells is even less clear but it has been suggested that rodent cell lines 
may heed as few as two events to generate neoplastic transformation, where 
as human cell lines perhaps require as many as seven independent events to 
generate a similar phenotype (Farber and Rubin 1991).
Clonal expansion of already initiated cells also appears to be a vital 
consideration in in vitro transformation assays since the subsequent growth 
of carcinogen treated cells appears to greatly influence the transformation 
frequency (Yao et a l, 1990).
Promotion of initiated cells, i.e. the stage of cellular alteration which leads 
to either oncogenic transformation in vitro or tumour formation in vivo, 
may occur spontaneously, but can also be enhanced by agents termed 
"tumour promoters". Probably the best studied class of tumour promoters are 
the phorbol esters and in particular TP A (12-0-tetradecanoyl-phorbol-13- 
acetate; the mode of action of this compound is considered in section 4.7). 
Promotion permanently alters initiated cells into a transformed 
tumourigenic state, this has been observed both in vitro and in vivo. 
Treatment of irradiated C3H lOTl/2 cells with TP A increased transformation 
frequencies (Kennedy 1978) and application of TP A to mouse epidermal tissue 
after treatment with the carcinogen DMBA (dimethylbenzanthracine) caused 
benign papillomas to undergo progression into malignant carcinomas. Often
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Ha-ms and subsequently c-myc oncogenes co-operate to bring about this 
phenotype (Balmain 1985).
Hence, carcinogenesis is the accumulation of sometimes several alterations 
all acting in unison to enable a cell to escape from normal cellular constraints, 
such as contact inhibition or reduced cell cycling times and ultimately leads to 
cancer formation. The study of carcinogenesis has many facets requiring the 
amalgamation of several lines of research involving hundreds of different 
techniques, only a very limited number of which it has been possible to 
comment upon and use in this study.
1.5 Aims of the thesis.
Ionizing radiation generates many wide ranging alterations within a cell, 
some permanent others just temporary. The objective of this study was to 
examine in particular, three aspects of human cellular responses to radiation. 1
1. The assessment of cytogenetic damage following irradiation in different 
human epithelial cell lines, using both immortal but non-tumourigenic cells 
and cells derived from similar human tissue but which were from a 
malignant source. This was carried out in order to gain an indication of 
differential radiosensitivities between normal and malignant human cell 
types.
2. The ability of radiation to induce neoplastic transformation in immortal 
but non-tumourigenic human epithelial cells and how this might differ from 
chemical induced transformation.
3. The induction of wild type p53 protein in response to irradiation of human 
epithelial cells of different origins and how the induction of this protein 
might influence post irradiation cell cycle delay so as to allow for increased 
DNA repair.
I
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MATERIALS AND METHODS
2.1 CELL CULTURE.
2.1a. SV-HUC lines.
Three SV-HUC lines were used, designated SV-HUC-1 or PC, NTH and BC16. 
These cell lines were derived from an eleven year old male road accident 
victim's uretral tissue which was judged to be free of any malignancy. The 
Human Uroepithial Cells were immortalised by infection with Simian Virus 40 
generating non-senescing cell lines that do not shed the live virus, i.e. non- 
permissive. The immortalisation of the these cell lines was performed by 
Dr.C. A. ReznikofPs group. University of Wisconsin, Dept of Human Oncology 
(Christian et al, 1988).
The culture media used was Hams F12 medium (Gibco) supplemented withl % 
fetal calf serum (PCS; Globepharm), human insulin (250 units/ml; Wellcome), 
hydrocortisone (Ipg/ml; Sigma), iron free human transferrin (5pg/ml; Sigma), 
nonessential amino acids (O.lmM; Gibco), dextrose (15mM; Sigma), penicillin 
(100 units/ml; Glaxo) and streptomycin (100|ig/ml; Evans). This medium is 
referred to as F12+ 1 % PCS. Cells were grown in plastic 75 cm  ^or 25 cm  ^tissue 
culture flasks, gassed with 5% CO2 in air and incubated at 370C. Alternatively 
cells could be grown in i0 0 mm petri dishes in a humidified incubator at 37®C in 
a 5% CO2 in air atmosphere. However, over prolonged periods of incubation 
fungal contamination became a problem using this second technique. Cells 
were covered with 10 mis of medium in the case of 100mm dishes & 75 cm  ^
flasks and 5 mis in 25 cm  ^flasks. (For all 25 cm  ^flasks the amount of each 
solution added was always half that given to the 75 cm  ^flasks). The medium 
was changed three times per week.
Cells were routinely dispersed and passaged before they reached confluence 
using 0.1% EOT A (Sigma) in Hanks' balanced salts solution pH 7.2. Cultures
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had F12 media removed and rinsed in 2mls 0.1% EDTA, this removed and 5mls 
of fresh 0.1% EDTA added before incubating at 37®C for 20 mins. The flasks 
tapped to dislodge cells and the cell suspension added to an equal volume of 
F12+ 1% FCS before centrifugation at lOOOrpm for 10 mins. A later alteration of 
this method was to add 1ml of 0.05% trypsin (Gibco) with 0.2% EDTA in PBS to 
the 0.1% EDTA after the 20 min incubation for approximately 60 seconds. This 
removed far more of the attached cells and increased the cell viablity. However, 
long incubation times in trypsin (1 0 mins+) resulted in cell death and greatly 
reduced viability (see Appedix Table A.1).
2.1b. Malignant bladder carcinoma cell line.
The cell line used MGH U l, has in fact been shown to be the bladder 
carcinoma cell line T24 by DNA fingerprinting tests (Masters et al.,1988). These 
cells were cultured in a similar way except the medium used was RPMI 
(Northmnbria Biologicals Ltd) supplemented with 5% FCS, antibiotics and L- 
glutamine (2.0 mM; Flow Laboratories). Cells were removed from flasks using
0.01% recrystallized trypsin (Cooper Biomedicals) with 0.2% EDTA in PBS at 
37®C for 10 mins.
2.1c. HFV cell line.
This cell line was immortalised by transfecting human foreskin explant tissue 
with a Human Papilloma Virus 16 recombinant plasmid construct (pMHPV16d). 
The immortalization was carried out by Dr. J A. DiPaolo, Laboratory of Biology, 
National Cancer Institute, Bethesda, MD. (DiPaolo et ah 1989). Cells were again 
cultured in a similar way to the SV-HUC and T24 lines except the medium used 
was 50% Hams F12/ 50% Dulbeccos (Gibco) supplimented with 7% FCS, 
hydrocortisone Ijxg/ml and antibiotics. The cells were passaged with 0.05% 
trypsin (Gibco) with 0.2% EDTA in PBS at 37®C for 10 mins. This line was used
;s
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as an example of a non SV40 immortalised but non tumourigenic epithelial cell 
line with which to compare p53 data from tlie SV-HUC lines.
2.1d HOS cell line. This cell line was derived from a Human Osteosarcoma 
and has been shown to be mutant for p53 Romano et al, 1989. Cells were 
provided by Dr. B, Vojtesek, Dept of Biochemistry, University of Dundee. The 
culture medium used was Dulbecco's Modified Eagles Medium (DMEM), 
supplimented with 10% FCS and 2  mM L-glutamine maintained at 37®C in 5% 
CO2  in air atmosphere. Cell dispersal was carried out using the EDTA/trypsin 
technique described in section 2.1a. HOS cells were used as a positive control 
when checking for the presence of mutant p53 protein.
2.1e H Tori-3 cell line. Cells were derived from human female thyroid 
epithelial tissue (Lemoine et al, 1989) and was provided by Dr. D. Wynford- 
Thomas, Dept of Pathology, University of Wales College of Medicine, Cardiff.
The cell culture procedure used was identical to that used for HPV cells. H 
Tori-3 cells were used as an SV40 immortalised control cell line with which to 
compare SV-HUC data.
2 . 2  PROTOCOL FOR CARCINOGEN TREATMENTS
2 .2 a. Cytotoxicity assesment of carcinogen treatments. (Figure 2 .1 ).
Since the SV-HUC lines do not readily form a viable single cell suspension the 
use of standard colony type assays could not be relied upon to give an accurate 
indication of cytotoxicity in these cell lines. Therefore a "regrowth assay" was 
utilized which did not depend on the generation of a single cell suspension.
MATERIALS AND METHODS 21
1x10  ^viable cells were plated in 25cm^ flasks in F12+ 1 %FCS medium for 48 
hours, after which this medium was removed and replaced with F12+ 0%FCS. 
The carcinogen treatment (radiation or chemical) was now carried out and 
cultures left for a period of 24 hours, before removing old media rinsing with 
F12+ 0%FCS and finally F12+ 1%FCS added back. The cultures were then 
incubated for 96 hours before cells were removed, counted and compared to 
control groups. Cell viability was checked by incubating 1ml of cell suspension 
with 50|il of 2% fast green (BDH) in 0.15M NaCl for 20 mins at37®C. Viable 
cells remained unstained whereas dead cells turned green in colour. Cell counts 
were carried out using haemocytometers. Triplicate samples were used for each 
cytotoxicity determination and calculated relative to cell survival from control 
cultures.
A similar protocol was used when determining cell viability with different cell 
culture techniques i.e. different media and dispersal methods. The cells were 
always incubated in FI2 + 1%FCS for the first 24 hours to allow cell attachment 
before being replaced with trial media. Cultures were again incubated for 96 
hours before harvesting and comparison to control samples (see Appendix 
Figure A.l)
For the cell line T24 where a viable single cell suspension could be obtained a 
colony assay was used to calculate a suvival curve following X-irradiation. This 
was carried out in 100mm plastic petri dishes. The number of cells plated was 
adjusted so that 1 0 0 - 2 0 0  colonies per dish were obtained after a six day 
incubation period. Dishes were then fixed in methanol for 10 mins and stained 
in 1 0 % Giemsa for 10 mins. Colonies of greater than 50 cells were scored.
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Ei.8.2âlCyt9tQxi€ity Assay.,
1x10  ^viable cells
25cm  ^flask. _
48 hrs
FI 2+ 0% FCS + Carcinogen for 24 hours.
F12+ 1% FCS
Harvest cells in log phase of growth, compare to controls.
Rinse with F12+0%FC^
Incubate in F12+ 1% FCS for 96 hrs
2.2b. Radiation treatments.
Cells were irradiated whilst attached to flasks. Initially cells were given 
various doses of 250 kv X-rays (0.5 mm Cu filtration). The dose rate was 0.74 
Gy/min. Later, due to failure of the X-ray facility, a gamma irradiator (Caesium 
137 isotope) was used to deliver the same doses of radiation. The dose rate was
4.6 Gy/min. Doses were checked using a ferrous sulphate technique 
(Frankenburg, 1969).
2 .2 c. Chemical carcinogen treatments.
All chemical carcinogens were dissolved in dimethylsulphoxide (DMSO; 
BDH). The final concentration of DMSO in cell culture was 0.5% with control 
groups being given the same amount of solvent without the carcinogen. All 
carcinogen treatments lasted for a period of 24 hours in serum free medium 
except that for 3-methyIcholan threne (MCA). MCA treatment lasted for 48 
hours, 24 hours in FI2+ 0%FCS medium after which serum was added back to 
the cultures upto 1% FCS again for a further 24 hours before rinsing and fresh 
FI 2+ 1%FCS medium added.
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2.3 CYTOGENETIC ASSESMENT OF RADIATION INDUCED DAMAGE.
2.3a. Micronucleus assay.
The cytogenetic response to radiation of SV-HUC lines and the T24 cell line 
was studied using the micronucleus assay. Micronuclei (MN) were assayed 
using the cytokinesis block technique (Fenech & Morley 1985). Briefly, 
immediately after irradiation cytochalasin B (Cyto B; Sigma; stock solution 
3m g/m l in DMSO) was added-to give a final concentration of 3pg/ml. Cultures 
were then incubated for 48 hours before harvesting with EDTA or trypsin.
2.3b. Preparation of slides.
Slides were prepared by centrifugation using a Shandon Cytospin 2 (800 
r.p.m. for 1 0  min) and fixed in methanol ( 1 0  min). Slides were then stained in 
56% Jenners in water for 5 min, rinsed in water, 25% Giemsa in water for 10 
min and again rinsed in water. Acridine Orange staining was performed on 
selected slides to check the accuracy of the Jenner/Giemsa staining technique 
using a method described by Tinwell and Ashby (1989). Briefly, Jenner/Giemsa 
stained slides were destained in methanol: acetic acid (3:1) overnight before 
staining with Acridine Orange 0.125 m g/m l dissolved in phosphate buffer 
(0.66% potassium phosphate monobasic + 0.33% potassium phosphate dibasic). 
Slides were stained for 60 s before two washes in phosphate buffer the first for 
10 min and the second for 15 min before mounting in buffer. Fluorescence 
microscopy was performed using 450-490 nm wavelength light. A total of 200 
Jenner/Giemsa stained binucleate cells were scored per sample per experiment.
2.3c. Karyotyping of cells. SV-HUC lines were grown to mid-confluence and 
treated with O.ljig/ml demicolcemid (Sigma) for 6  hours. Cells were removed
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from flasks, spun, incubated with 10 ml of 75mM KCl for 10 min at 37®C before 
fixing with cold acetic acid /  methanol (1:3). Preparations were washed three 
times in acetic acid /  methanol, left overnight at 4®C and resuspended in a small 
volume of fixative. Chromosome spreads were prepared by dropping aliquots 
of cell suspension onto clean, wet, cold slides followed by the same size aliquot 
of fixative. Slides were air dried and stained directly with 3% Giemsa (BDH) in 
water or used for G-banding. For G-banding slides were treated with a 0.125 % 
trypsin solution (Gibco) in 0.85% NaCl buffer for 10 seconds, rinsed three times 
in buffer before staining with 3% Giemsa. 50 metaphase spreads were scored to 
gain modal chromosome numbers.
2.4 TRANSFORMATION EXPERIMENTS.
2.4a. Protocol for SV-HUC transfomation experiments. (Figure 2 .2 ).
The carcinogen treatment was carried out as described previously. Some 
carcinogen treatments were carried out twice with a recovery period and split of 
the cells between each treatment. When split the cells were replated at a 
concentration of 1x10  ^cells per flask, left for 48 hours and again treated with the 
carcinogen as above. The cultures were then allowed to continue growing until 
almost confluent whereupon they were split and used to reseed three new flasks 
at approx 1.5x10  ^cells per flask. These cultures were again allowed to almost 
reach confluence, split ^/3rd and new flasks seeded except that each flask was 
now used to reseed just one flask each i.e. no further "bulking up" of cells. This 
continued passaging was carried out six times following final carcinogen 
treatment over a period of eight weeks with medium changed three times per 
week. At the sixth split the three flasks of the same treatment were pooled, 
resuspended in 0 .2 ml of F1 2 + 0 % FCS medium ready for inoculation into nude
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mice. Cells of similar treatments were not pooled during the experiment except 
if they were derived from the same initial flask following carcinogen treatment.
The effect of postconfluent growth inhibition (i.e. cells maintained at Go) 
following carcinogen exposure (as with rodent cells) was also investigated. 1 
xlO  ^cells were plated and treated using an identical carcinogen exposure 
protocol as described above. Cultures were then grown to confluence before 
passaging and a second carcinogen exposure, or held at a confluence depending 
on the treatment protocol used (Figure 2.3). Once such cultures had attained 
confluent inhibited growth they were maintained in this state for a period of 
eight weeks and the medium changed three times per week. Cellular 
transfomation in such cultures was assayed by the formation of dense 
"transformed colonies" growing on top of a growth inhibited or plateau phase 
monolayer of cells. Using the EDTA/trypsin method cells could be removed, 
inoculated into nude mice or checked for colony formation in 0.3% agarose.
These dense type colonies could be seen without staining but a sample were 
fixed with methanol for 10 min and stained with 10% Giemsa in water for 10 
min. The larger of these colonies could be picked off and transplanted into a 
new culture flask where upon they continued to grow as a dense/tight colony of 
cells. After a further 6 - 8  week incubation period such colonies could be fixed, 
sectioned and stained in a similar way to that for the tumour biopsies from the 
nude mice. These colonies were also inoculated into nude mice and checked for 
tumour formation.
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Fi  ^2.2 Transformation experiment protocoL
1x1 0  ^viable 
cells
1 0 0 mm dish or 
75 cm^  flask.
48 hrs
FI2+ 0% FCS + Carcinogen for 24 hrs. ---- Rinse with F12+0%FCS
F12+1%FCS
Alternatively, some cultures were held at confluence for a period of 6 - 8  weeks and checked for "transformed" colony formation.Figure 2.3.
Incubate in F12+ 1% FCS until almost confluent. The time taken depends on the level of cell killing, approx 7-14 days.
Split 1 initial flask into 3 new 
culture flasks. Approx 1.5x10  ^
cells per flask. Again grow until 
almost confluent, split and replate 
l/3rd of cells. | j
Continue to passage 6  times following carcinogen treatment.1 1  1
Pool the 3 flasks of the same treatment at final split, resuspend 
6-8x10  ^cells in 0.2ml of FI 2+ 0% FCS medium and inoculate 
4-6 week old nude athymic mice s.c. .Leave for up to 6  months 
and check for tumour formation.
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Fig 2.3. Experimental protocol for postconfluent growth inhibition transformation.
Carcinogen treatment as in Figure 2.2.
I
Grow until confluent (or just sub-confluent before passaging if a second carcinogen treatment is to be carried out).
After final carcinogen exposure maintain at confluence for 6 - 8  weeks in F12+ 1% FCS (media changed 3 times per week).
Score flasks for "transformed colonies"
Remove cells with EDTA/trypsin
Plate cells in semi-solid medium (0.3% agar) and look at colony forming ability.
Pick off transformed colony and transplant to new flask. Leave to grow for a further 6 - 8  weeks.
Remove colony as a solid mass of cells.
Inoculate nude mice and check for tumour formation.
2.4 b. Inoculation of cells into nude mice.
The ability of control and carcinogen treated cells to form tumours was 
assayed by inoculation of 6 - 8  xlO  ^cells into 4-6 week old athymic nude mice. 
Mice were originally from OLAC Ltd; strain MFl-nu/nu (athymic), but once a 
breeding stock was established exprimental animals were taken from this stock. 
The cells were injected suspended in a volume of 0.2mls of F12+ 0% FCS sub- 
cutaneously mid way between the fore and hind limbs in lateral position. 
Animals were examined weekly for tumour formation and sacrificed if any
..f
2.5 IMMUMOCHEMISTRY AND ELISA TESTS.
2.5 a. Immunocytochemical staining with substrate specific monoclonal 
antibodies.
Cells from three main sources were stained with antibodies; Fixed and 
sectioned biopsys from nude mice, cells grown on glass cover slips and cells 
grown on plastic petri dishes. The antibodies used were against three main 
protein complexes.
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tumour reached > 1  cm in diameter, if necrosis occurred or after six months i.e. %
full term experiment. Tumour biospsies were split into two halves. One half ?
was fixed, sectioned and stained with haematoxylin and eosin or monoclonal 
antibodies to human cytokeratin and the SV40 T-antigen to confirm the origin of '
any tumours obtained. The other tumour section was disscected into 1mm |
cubes and placed with a small amount of FI2 + 1 % FCS medium on the base of a {
culture flask to try and generate a cell line. The cell line T24 was used as a |
positive control for tumour formation in the nude mice but the medium used |
was RPMI. i
2.4 c. Growth of cells in 0.3% agar. |
The ability of cells to grow in semi-solid medium was assayed for both control |' icells and those showing a dense type colony appearance from the 1
transformation experiments where cultures were left at confluence. 1 x1 0  ^viable 
cells per 60mm dish were plated in 2ml of F12+ 1%FCS medium containing 0.3% :>
agarose over 2 ml of F12+1% FCS, 0.5% agarose underlayer. Dishes were |
incubated in 95% air 5% CO% atmosphere at 37®C for 2 1  days. Five Icm^ fields |
were scored per plate per treatment for colonies of greater than 50 cells.
Triplicate plates were prepared per treatment.
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1. The SV40 T-antigen to indicate that the cells concerned were immortalised by 
SV40. The antibody used was a mouse monoclonal designated PAb 405 which 
reacts with a region of the T-antigen close to the C terminus of the protein.
2. Human cytokeratin to indicate that cells were of human origin. The antibody 
used was a mouse monoclonal which reacts with several forms of human 
cytokeratin (DAKO M821)
3. The p53 protein in both wild type «& mutant conformations and following 
radiation treatment. All antibodies were mouse monoclonals.
ANTIBODY SPECIFICITY
PAb 240
Reacts with human, mouse, rat, hamster, bovine and chicken. 
Epitope lies between amino adds 156-214. Will not bind to 
p53 when it is complexed to SV40 T-antigen. PAb 240 
recognises mutant but not wild type p53, also bind to HSP70. 
All known activating mutations in p53 result in a common 
conformational change which are detected by PAb 240.
PAb 246
Reacts with mouse only.
Epitope is between amino adds 88-109 but will not react with 
p53 having mutations which lie between 120-240,i.e. mutations 
here have a conformational effect elsewhere. Will bind to p53 
when complexed with T-antigen but not with HSP70.
PAb 421 Not specific to one species, mouse, human etc. 
Binds to C terminus of mutant and wild type p53.
DO-1
Reacts with human, monkey bovine but not mouse.
Mutant and wild type p53 detected but greater affinity for wild 
type than PAb 421. Epitope in N-terminus region aa 1-45.
Table 2.1, Taken from Gannon et al, 1990, Levine 1990 and Vojtesek et ai, 1992.
However, all antibodies will react both with wild type and mutant forms of 
p53 if the protein is denatured i.e. after fixation. Hence the use of ELISA tests 
was required to determine between mutant and wild type protein and also in 
quantitative assays. All antibodies unless otherwise stated were obtained from
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quantitative assays. All antibodies unless otherwise stated were obtained from 
Dr. D. Lane, Dept of Biochemistry, University of Dundee. See table 2.1 for 
details of p53 antibody epitope specificity.
The protocol in all cases remained essentially the same except no fixing was 
required in biopsy samples. The method described initially is for all primary 
antibodies except M821, where differences in methodology apply they will be 
described later.
2.5 a.l. SV40 T-antigen and wild type p53 protein staining 
Cells were fixed in cold methanol/acetone (1:1) for 2 min in the case of all PAb 
and DO-1 monoclonals before being allowed to air dry. The primary antibody 
was then used neat in the form of hybridoma culture supernatant or ascites fluid 
diluted 1:500 in PBS, incubated at room temperature for 1 hour in a humidified 
atmosphere. Specimens rinsed three times in PBS before the secondary 
antibody with 5% FCS to prevent non specfic binding added for a further 1 hour 
at room temperature. The secondary antibody was a rabbit anti-mouse IgG 
horseradish peroxidase (HRP) conjugated polyclonal antibody (P161 DAKO) 
diluted 1:100 in PBS if the section was to be viewed with an ordinary light 
microscope. If the section was to be examined under fluorscence with a confocal 
microscope then the secondary antibody was a sheep anti-mouse IgG FITC 
(Fluoresein Isothiocyanate) conjugated polyclonal antibody (S121-201 Scottish 
Antibody Production Unit-SAPU) diluted 1:20 in PBS. The secondary antibody 
was then washed off as above before developing with 3’, 3-diaminobenzidine 
(DAB; Sigma) in the case of the HRP IgG antibody. DAB was used at a 
concentration of Im g/m l in water with 0.03% nickel sulphate (to enhance a 
black colouration) and activated with 0.06% H2O2 and left for 5-10 min in the 
dark before removing the DAB solution. Specimens for use with the confocal 
microscope (krypton/argon mixed gas laser, wavelength 488 nm) could be
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viewed directly but were mounted in 90% glycerol/10% PBS with 25mg/ml N- 
propyl gallate (Sigma) as an anti-fading agent.
2.5 a.2 . Human cytokeratin staining.
Immunocytochemical staining using anti-cytokeratin antibodies was carried I
out on samples fixed in cold acetone for 2 0  min and then rehydrated in 1 % ^
sheep serum (SAPU) in PBS for 30 min. The primary antibody M821 was >
incubated at 37®C for 1 hour diluted 1:25 in 1% SSPBS. Rinsed three times in IPBS and the secondary antibody a sheep anti-mouse HRP conjugated polyclonal f
antibody (S081-201; SAPU) diluted 1:20 in 1% SSPBS added for 1 hour at 37®C.
The remainder of the protocol is now the same as for the PAb antibodies. j
■II
2.5 b. Enzyme-linked immunoabsorbant assay (ELISA) for p53 protein.
(Figure 2.4).
ELISA tests were performed to quantify the level of wild type p53 protein #
present after radiation treatment. The technique can be split into three seperate r
procedures.
1. Generation of a protein extract by cell lysis.
2 . Measurement of the total amount of cellular protein in the extract. ;:
3. The EUSA itself.
1
2.5 b.i. Cell lysis; Cell lines SV-HUC-1 (PC) and HKc were irradiated in Î 
75cm2 flasks as described previously. Three sub-confluent flasks per data point
were used. Cells were then harvested, washed and spun (lOOOxg for 10 mins)
three times in PBS before finally pelleting the cells and freezing at -70®C. Cell
lysis was carried out in NET lysis buffer (50 mM Tris; BRL, 150mM NaCl, 5mM |
EDTA; Sigma, 1% NP-40; BDH, 350pg/ml phenylmethylsulfonyl fluoride; BRL. ^
Harlow and Lane,1988). 1ml of NET buffer added to the cell pellet, vortexed i
and left on ice for 30 mins before centrifugation at 10,000xg for 30
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mins at 4®C. The supernatant containing the protein extract was then diluted in 
NET buffer through a series of nine 50% dilutions to generate samples for a 
titration curve.
2.5 b.2 . Measurement of the total amount of cellular protein. This was 
assayed using Bradford dye (BioRad). Briefly, a 1:20 fold dilution of the protein 
extract in water was carried out. Then Ipl of this diluted cell extract added to 
lOOpl of water and 1ml of Bradford dye added. The absorbance was then 
measured at 595 nm compared to a control of lOOpl water plus 1ml of Bradford 
dye. A reading of 0.095 corresponding to Im g/m l of protein. The amount of 
cell extract added to each well was then be adjusted so that all wells of the same 
dilution received tlie same quantity of protein.
2.5 b.3 . ELISA. The assay itself was performed in flexible PVC 96-well 
microtitre plates (Falcon). Plates were coated w4th the primary antibody (DO-1 
or PAb) over night in a humidified atmosphere with 50|ol per well of 30|ig/m l 
antibody (neat) if hybridoma culture media or ascities diluted 1:500 in coating 
buffer (O.IM NazCOs/NaHCOg, pH 9). Plates were then rinsed in PBS and 
blocked for 2 hours with 3% Bovine serum albumin (BSA-ELISA grade; Sigma)  ^
in PBS at room temperature. The BSA was then removed and rinsed with PBS 
(xl), PBS+O.1% NP-40 (x3), PBS (xl) before the cell extract added for 2 hours at 
4®C. Two wells in each row remained free of protein extract and received just 
lysis buffer which served as controls. The same washing procedure was carried 
out followed by addition of rabbit antiserum to p53, CM-1 (David Lane) diluted 
1:500 in 1% BSA for 2 hours at 4®C. This antiserum contained the second p53 
antibody which is non-specific and binds all the different forms of p53 protein.
After washing using the same protocol, peroxidase-conjugated swine antiserum 
to rabbit immunoglobulins (DAKO; P217) diluted 1:500 in 5% FCS in PBS was 4
added for 2 hours at 4®C. Again washed using the same method and 
visualisation carried out using tetramethylbezidine (TMB; Sigma). TMB 
dissolved in DMSO at lOmg/ml was diluted 1:100 in substrate buffer (O.IM
4
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Na2HPO4 / 0 .1 M citric acid, pH 6.0) add activated with 0.06% H2O2 .50pl of this |
solution was added to each well, left in the dark for 2 0  mins and the reaction 
stopped with IM H2SO4 (50 p.1 per well). The plate was then analysed on an 
automatic plate reader at 450 nm.
Fie 2.4. Summary of procedure for ELISA.
Pre-coat plates with primary spedfic p53 mouse monoclonal antibod)
I
Wash wells and block with 3% BSA
IWash wells, add known quantity of protein from cell extracts to each well and generate standard titration curve.
I
Wash wells, add second p53 antibody (rabbit). Non-specific, binds any p53 protein, mutant or wild type.I
Wash wells, incubate with peroxidase-conjugated swine anti-rabbit antibody. ,
f
Wash wells, develop with TMB/sulphuric acid and read at 450 nm
2.6 IMMUNOPRECIPITATION AND WESTERN BLOT ANALYSIS OF 
MUTANT p53 PROTEIN. (Figure 2.5).
Cell lines were checked for the presence of mutant p53 protein using 
immuoprecipitation and western blot analysis followed by subsequent antibody 
staining of the nitrocellulose membrane. Again the technique can essentially be 
split into three procedures.
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1. Generation of a protein extract and immunoprécipitation with specific 
monoclonal antibodies.
2. Polyacrylamide Gel Electrophoresis (PAGE) and electrophoretic transfer onto 
a nitrocellulose membrane.
3. Antibody staining of the nitrocellulose membrane coupled with visulisation 
of bound antibodies.
2.6 a. Generation of protein extract and immunoprécipitation.
The protein extract was produced using exactly same protocol as decribed for 
ELISA experiments i.e. NET lysis buffer at 4®C (see section 2.5b.i.). Following 
cell lysis, extracts (600jxl aliqots) were pre-adsorbed with 40|jI protein G- 
Sepharose (Sigma) washed in NET lysis buffer to remove the ethanol. This was 
carried out on a rotating wheel at 4®C for 40 min and the protein G-Sepharose 
pelleted by centrifugation at 14K for 2 min. 200pl of cell extract was then 
incubated with Ipl of ascities containing the primary specific monoclonal, DO-1, 
PAb 240 or anti-retinoblastoma (Rb) mutant protein antibodies (IF8 ; D. Lane, 
Dept of Biochemistry, University of Dundee). The IF8  antibody was used as an 
"irrelevant antibody" to check for non-specific binding of the second anti-p53 
antibody CMl. Ths incubation was performed at 4®C over night. To this was 
added 20pl of protein G-Sepharose for 40 mins at 4®C on a rotating wheel to 
precipitate out the antibody-p53 protein complex. Following 
immunoprécipitation the samples were spun at 14K for 5 min and the sediment 
washed 4 times in lysis buffer. An equal volume (50pi) of sample buffer was 
then added to the protein G-Sepharose - antibody - p53 protein complex, boiled 
for 5 min and spun at 14K for 8  min. (Sample buffer 2x concentrate pH 6 .8 ; 4% 
sodium dodecyl sulphate (SDS; BDH), 120 mM Tris (BDH), 20% gylcerol (Serva) 
and 0.002% bromophenol blue (Sigma)). 40ml of this sample could then be 
loaded onto the 1 0 % acrylamide gel.
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2.6 b. Electrophoresis and electrophoretic transfer.
Samples were run on a 10% SDS-PAGE gel with a stacking gel of 4%, 1.5mm 
thickness. 10% gel constituents; 12.5ml of 1.5M Tris pH 8 .8 , 0.5ml of 10% SDS, 
16.67ml of 30% acrylamide (Sigma), 20.33 ml of distilled water and polymerized 
with 400|ol of APS (ammonium persulphate; Fluka) and 40pl of TEMED (N,N' 
-methylene-bis-acrylamide; Sigma), approx 1 hour to set. 4% gel constituents; 
2.5ml of 0.5M Tris pH 6 .8 , 1.3ml of 30% acrylamide, 0 .1 ml of 10% SDS, 6.1 ml of 
distilled water, polymerized with 50pl of APS and lOpl of TEMED. The gel was 
run at 36mA for approximately 3 hours on a Gibco/BRL apparatus with a 
running buffer of 0.025 M Tris, 0.24 M glycine and 0.1% SDS,
Electrophoretic transfer was carried out using a semi-dry technique with a 
transfer buffer of 0.025 M Tris, 0.192 M glycine, 20% methanol and 0.0375%
SDS. The apparatus used was an LKB 2117 Multiphor II electrophoresis unit at 
0.8 mA per cm  ^for 2 hours to transfer protein onto nylon backed nitrocellulose 
(Hybond-C extra; Amersham).
2.6 c. Immunoblotting of nitrocellulose with antibodies and visulisation.
The nitrocellulose membrane was first incubated with 3% BSA in PBS for 2  
hours at room temperature to block nonspecific binding sites. The second 
nonspecific, anti-p53 antibody (CMl) diluted 1:500 in 3% BSA in PBS was added 
for 1 hour at 37®C. Following four washes in PBS, HRP conjugated swine anti­
rabbit immunoglobulins diluted 1:500 in 3% BSA in PBS was incubated for a 
further 1 hour at 370C. After washing in PBS visulization was carried out using 
DAB/H 2 0 2 /nickel sulphate as described for immunocytochemical staining 
(1 0 ml of Im g/m l DAB, 150pi 3% NiSO& 15|il of 30% H2 O2 ; see section 2.5a.). i
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Fig. 2.5. Summary of procedure for Immunoprécipitation and Western Blotting
Produce cell lysate (NET lysis buffer).
IPre-adsorb lysate with protein G-sepharose
I
Incubate lysate with primary specific mouse monoclonal antibody.
. . iImmunoprecipitate the p53 protein-antibody complex with protein G-sepharose. |
Boil p53-antibody-protein G complex to release and denature p53 protein. |
Run samples on 10% acrylamide gel
I
Electrophoretic transfer of proteins from gel to nitrocellulose.
Block nitrocellulose membrane with 3% BSA in PBS.
♦Incubate with secondary non-specific rabbit anti-p53 antibodies (CMl)
jIncubate with swine anti-rabbit HRP conjugate antibodies. 
Develop membrane with DAB/nickel sulphate/H 2O 2 .
2.7 FLOW CYTOMETRIC ANALYSIS OF CELL CYCLING FOLLOWING 
IRRADIATION.
Cells were grown in 75cm^ tissue culture flasks and irradiated in mid 
logarithmic growth. One hour prior to cell harvest lOpM of BrdU (5-Bromo-2- 
deoxyuridine; Sigma) in PBS was added to the culture medium for 
incorporation into cells undergoing active DNA synthesis. After harvesting of 
cultures with trypsin/EDTA as previously described cells were washed in PBS
"3
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i
fixed in 70% ethanol overnight at 4°C. Following washing in PBS cells were 
resuspended in 2.5mls of 2M HCl containing 0.1 m g/m l pepsin (Sigma) for 20 |
mins at room temperature. After washing a further two times in PBS cell nuclei /
were now ready for antibody staining. Nuclei were resuspended in O.Smls of 
PBS containing 0.5% goat serum (SAPU) and 0.5% Tween 20 (ICN Biochemicals) 
before addition of 25pl of anti-BrdU rat monoclonal antibody for 1 hour at room 
temperature (2 0 m g/m l hybridoma culture media; Haddow Laboratories).
Nuclei were then centrifuged at 2 0 0 0 rpm for 5 mins in 5 mis of PBS, 
resupended in O.Smls of PBS/goat serum/Tween 20. To this was added lOjil of 
goat anti-rat IgG FITC conjugate (Sigma; F-7250) for Ihour at room temperature.
^Samples were washed in 5mls of PBS, resupended in 1 ml PBS containing fresh 
RNase (BRL; Img/ml) for 30 mins at 37°C before addition of propidium iodide 
(Sigma; 4pg/ml). Samples were then analysed using a flow cytometer 
(FACScan; Becton Dickinson). The softwear associated with FACScan 
interpreted the data giving both a cell cycle profile (see figures 5.9 and 5.10) and 
information concerning the percentage of cells in Gi, S and G2 /M.
For simple, single channel staining of DNA only the procedure from * was 
followed after harvesting cells and fixation in alcohol.
J
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FIG 2.6. Procedure for BrdU / antibody / proDidium iodide 
staining in conjunction with the FACScan for cell cell analysis 
following y irradiation.
Cells incubated with IQig/ml BrdU for 1 hour in culture media
t
Harvest cells with trypsin/EDTA, wash with PBS
i
Fix cells in 70% ethanol overnight at 4°C, wash with PBS
t
Remove cell cytoplasm using 2M HCl containing 0. Img/ml pepsin (20 mins at room temperature). Wash twice with PBS.
I ■
Stain with anti-BrdU rat monoclonal for 1 hour at room temperature, wash with PBS. ,
T
Probe with goat anti-rat FITC conjugated IgG for Ihour at room temperature, wash with PBS. •
T
Treat with RNase (Img/ml for 30 mins at 37°C).
t
Stain with propidium iodide (4|ig/ml 30 mins at room temperature).
I
Analyse cell cycle profile using FACScan.
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CHAPTER 3
CYTOGENETIC RESPONSES OF HUMAN 
UROEPITHELIAL CELL LINES AND A MALIGNANT 
BLADDER CARCINOMA CELL LINE TO X-RAYS.
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3.4 The effect of Cytochalasin B on Mn formation.
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CYTOGENETIC RESPONSES OF HUMAN 
UROEPITHELIAL CELL LINES AND A 
MALIGNANT BLADDER CARCINOMA 
CELL LINE TO X-RAYS.
ABSTRACT
3.1
The response to X-rays of three Simian Virus 40 (SV40) immortalized but 
non-tumourigenic human bladder epithelial cell lines have been compared 
with a malignant bladder epithelial cell line using the micronucleus assay. ^
An optimal concentration of Cytochalasin B was found to be 3pg/m l to 
induce binucleated cells for the scoring of micronuclei (Mn). A linear increase 
in radiation induced Mn was observed for all cell lines with increasing X-ray 
dose. The three SV40 immortalized lines were significantly less 
radiosensitive than the malignant cell line. Spontaneous levels of Mn 
indicate that certain cell lines within the SV40 immortalized lines have a 
higher genetic instability. This may be of importance when considering the 
generation of a fully transformed or tumourigenic phenotype after treatment 
with physical or chemical carcinogens.
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INTRODUCTION
3.2
The effects of ionizing radiation on cells can be measured using a variety of 
different assays which vary greatly in terms of the end point used and the 
biological system chosen. Classically reproductive "cell death" as measured by 
colony type assays provided a lot of information concerning the cytotoxic or 
lethal nature of radiation. These assays were used largely on established cell 
lines such as rodent fibroblasts (eg. C3H 10 T^  Hi, or cell lines generated from 
human malignancies. As mentioned in the main introduction these 
probably don’t represent an accurate model for normal human epithelial 
tissues where a majority of human neoplasms originate.
Clonogenic assays give information about the toxic nature of ionizing 
radiation by measuring it's effect on the "reproductive integrity" of the cell 
(Hall 1988), i.e. it's proliferative capability following radiation treatment. This 
is usually expressed in terms of a survival curve. A prerequisite for using a 
colony type assay is the ability to generate a viable single cell suspension 
which itself can cause difficulties with certain cell types and lines. Clonogenic 
assays don't however provide data concerning the more immediate effects of 
ionizing radiations on the critical cellular target - nuclear DNA.
Cytogenetic analysis of chromosome and chromatid aberrations following 
radiation does provide data concerning the clastogenicity of ionizing 
radiation. However, scoring of these aberrations can be a lengthy and 
complex process requiring good quality metaphase spreads. The generation of 
these spreads can itself provide problems especially during long colcemid 
incubations for cells with long cell cycle times due to chromosome 
condensation and shortening (Sharma and Sharma, 1980).
Another method which scores aberrant acentric chromosome fragments 
that do not associate with the nucleus at nuclear division is that of measuring
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micronuclei (Mn) formation. Although not as sensitive at measuring 
radiation induced chromosome damage as aberration scoring, Mn do provide 
an indicator of unrepaired damage at the chromosomal level, which are 
quicker and easier to score than the above mentioned aberrations. One 
reason for this disparity between Mn frequency and that of aberration 
frequency is that not all acentric fragments may be excluded from the nucleus 
at nuclear division. (Reviewed by Savage 1988),
H.C r CHH3C—CH/HjC\HC.\ HC
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Fig. 1 . Chemical structure of the 
alkoloid Cytochalasin B.
Cytochalasin B
A modification of this technique was developed by Fenech & Morley 1985 
using an agent that inhibits cytokinesis (cellular division) whilst still 
allowing nuclear division to occur. Cytochalasin B (Cyt B; Figure 3.1), an 
alkaloid which interferes with the assembly of actin filaments so preventing 
cellular division is such an agent, since it does not interfere with 
microtubules of the nuclear spindle so allowing nuclear division to take place 
(Stryer 1981). The use of this technique is now employed widely for studying 
a large range of genotoxic agents, both chemical and physical (Arlett et al., 
1989). The use of such a cytokinesis block method has two important
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consequences when scoring Mn. Firstly Mn are far easier to score and 
secondly cells which have only been through one nuclear division can now 
be selected and scored. This allows cells from a similar "time window" to be 
scored i.e. they have cycled to the same extent following radiation, the 
significance of this will be commented on in the Discussion.
Another advantage of scoring Mn as a measure of radiation induced 
damage is that a viable single cell suspension or good quality metaphase 
spreads are not required. Both of these proved difficult to obtain for SV-HUC 
lines.
PROCEDURE
3.3
Irradiated cultures were incubated with Cyt B to obtain binucleate cells 
which were scored for Mn. The radiosensitivity of all four epithelial lines 
was assessed in this way. Spontaneous Mn levels were also examined in 
unirradiated samples to gain a measure of the genetic instability within each 
line. Two different methods of staining were employed to check the validity 
of Mn generated after Cyt B incubation.
The radiosensitivity as measured by surviving fractions in a clonogenic 
assay was also determined in T24 cells for which a viable single cell 
suspension could be obtained. Since the radiosensitivity for this cell line had 
now been measured by two different techniques this enabled approximate 
extrapolations to be made concerning the relative survival of SV-HUC lines 
following irradiation.
Finally Mn levels following irradiation were also used to determine the 
clastogenic effectiveness of two different radiation sources.
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RESULTS
3.4 The effect of cytochalasin B on Mn formation.
A suitable working concentration of Cyt B was found to be Spg/ml (final 
concentration in cell culture). The binucleate cell index plateaus at 
concentrations at and above 3pg/m l indicating that cells are no longer 
escaping cytokinesis blockage. There is little effect of increasing Cyt B 
concentration on the spontaneous Mn formation, and appears to actually be 
decreased slightly by higher doses of Cyt B (Figure 3.2).
3.5 Mn frequencies in different cell lines following irradiation.
In multiple sampling experiments (Figure 3.3) the effect of harvest time on 
Mn formation in irradiated cells blocked with Cyt B was investigated. These 
results indicate that there is no definite peak in Mn response following 
radiation at a given harvest time, but increases steadily with sampling time. 
NTH cells were found to be considerably less sensitive than the bladder 
carcinoma cell line T24 in terms of Mn response to X-rays at comparable 
harvest times. This is also demonstrated by the X-ray dose-response curves 
obtained at a fixed harvest time of 48 hours (Figure 3.4). The three SV-HUC 
lines all show similar dose-response curves to one another, these being far 
less steep than that of the T24 cell line. At 6  Gy there was a significant 
difference between the Mn response of SV-HUC-1 (the most sensitive of the 
SV-HUC lines) and that of cell line T24 of P< 0.01, Student’s t-test. all four 
lines showed a linear increase in frequency of induced Mn with X-ray dose at 
the 48 hour sampling time.
Although the cell cycling times of the cell lines in exponential growth were 
found to be approximately 39,42, 43 and 20 hours for cell lies NTH, SV-HUC- 
1 (PC), BC16 and T24 respectively, a harvest time of 48 hours was found to be
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Fig. 3.2, Effect of Cytochalasin B on spontaneous Mn formation and cytokinesis blockage in SV-HUC-1 cells. Sampling time 48 hours after addition of Cytochalasin B.
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Fig.3.3. Frequency of Mn in binucleate cells as a function of time following X-irradiation (4.0 Gy). Error bars represent standard errors of mean (SEM) values from two separate 
experiments.
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an optimal sampling time from experiments using multiple sampling times.
At sampling times later than 48 hours the frequency of binucleate cells 
(binucleate index) fell to levels which made accurate scoring of Mn difficult. j
Conversly at sampling times much shorter than 48 hours the binucleate 
index is also low since not enough time has elapsed since the addition of Cyt 
B to allow a sufficient number of cell to accumulate in the binucleate cell i
compartment. Figure 3.5 shows that the maximum binucleate index occured 
at approximatley 48 hours for cell lines N Tll and T24.
The survival curve of T24 cells to X-rays (Figure 3.6) gave a point of 
reference for a comparison with the Mn dose-response curves. SV-HUC lines 
would be expected to show increased survival to X-irradiation when 
compared to T24 cells and is indicated by the dotted line.
Figure 3.7 shows the relationship between surviving fraction and the 
number of cells that do not contain Mn following radiation treatment for cell 
line T24. In general terms the increased generation of Mn can be seen to 
coincide with an increase in cell death (see Discussion for more detailed 
explanation).
The spontaneous level of Mn after Cyt B blockage alone (Figure 3.8) was 
found to be high for cell lines SV-HUC-1 and N Tll but far lower for that of 
BC16 and T24. The difference between BC16 and both SV-HUC-1 and N T ll 
was significant at the P= < 0.05 level. Students t-test. The spontaneous Mn 
levels observed in cell lines BC16 and T24 fall within the range of values 
obtained for other human cells such as lymphocytes; 4.0-67.3 M n /1000 
binucleate cells (Fenech et ah, 1990).
3.6 Staining of Mn.
Acridine Orange (AO) staining was performed on selected slides to check 
for possible artifacts resulting from the Jenner/Giemsa staining. Cytospininng 
when coupled with the Jenner/Giemsa stain gave a very good contrast
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Fîg.3.6. Cell survival curve for cell line T24. Error bars represent SEM values from at least three separate experiments. The dotted line representsthe approximate survival curve for SV-HUC lines. Calculated from data in Fig. 3.7. and Table 3.1.
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Fig.3 .7 . Plot of surviving fraction against cells without Mn following irradiation for T24 cells. The solid lines represent the corresponding values from an SV-HUC line taken from Table 3.1. All sampling times of 48h.
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Fig.3.8. Spontaneous frequencies of Mn in binucleate cells 48 h after addiation of Cyt B. Error bars represent SEM values from at least three separate experiments.
Radiation Dose in Gray Surviving Fraction Number of cells without Mn/100 binucleate cells
Cell line T24
0 1 .0 1 0 00.5 0.815 78
1 .0 0.530 581.5 0.443 49
2 .0 0.249 443.0 0.126 344.0 0.053 1 1
6 .0 0.006 5
Cell Ime SV-HUC-1
0 1 .0 * 1 0 0
1 .0 0.85* 83
2 .0 0.61* 674.0 0.25* 45
6 .0 0.095* 27
Table 3.1. Data for cell lines T24 and SV-HUC-1 relating surviving fractionto the number of cells not containing Mn following radiation treatment.* Values were calculated from Fig. 3.7, these data provide the basis of the approximate survival curve for the SV-HUC lines shown m Fig. 3.6..
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between cytoplasm (blue) and the nuclei or Mn (mauve; Figure 3.9). Another 
advantage of this method was that the distribution of cells on the slide was 
predictably in one area with cells in relatively close proximity. Thus, 
boundaries of cell cytoplasm could be easily identified. These factors allowed 
accurate scoring of slides much more rapidly than with standard spreading 
techniques. The staining with AO (Figure 3.10) indicated that the Mn 
produced are nuclear fragments and not artifacts of the Jenner/Giemsa stain.
Immunocytochemical staining for the SV40 T-antigen was positive for the 
SV-HUC lines (Figure 3.11) but no staining was observed with the malignant 
bladder cell line T24.
Finally, after failure of the X-ray source the "relative biological 
effectiveness; RBE" (Hall 1988) was checked be ween X-rays and Gamma rays 
for identical doses using the same end point, i.e. induced Mn following 
irradiation. The results indicate that there is no significant difference between 
X-ray and Gamma rays over the dose range used (0-6 Gray) in terms of 
induced Mn following radiation treatment (Figure 3.12).
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Fig.3.9. A Jenner/Giemsa stained binucleate NTll 
cell 48 h after 4.0 Gy X-irradiation and cytokinesis 
blockage with 3|ig/ml Cyt B. The arrows indicate 
Mn within the cell cytoplasm. Scale bar represents 
1 0 pm.
Fig.3.10. Acridine Orange fluorescence of binucleate 
NTll cells 48 h after 4.0 Gy of X-rays and cytokinesis
blockage with 3pg/ml Cyt B. Several Mn per cell are shown 
and the boundaries of cell cytoplasm can be clearly 
distiguished as with the Jenner/Giemsa stained samples.
Scale bar represents 10pm.
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Fig.3.11. Immunocytochemical staining of SV-HUC-1 
cells with antibodies against SV40 T-antigen. The 
cytoplasm & nucleolus have remained unstained, 
whilst the nucleus has stained darkly. Scale bar represents 
1 0 pm.
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D o se  of radiation in Gray
Fig. 3.12. Comparision of the effects of X-ray and 
Gamma radiation on Mn formation in SV-HUC-1 
cells. Sampling time was 48 h and error bars 
represent SEM values from three separate 
experiments.
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DISCUSSION
3.7 The optimal concentration of Cytochalasin B.
The original work of Fenech & Morley 1985 used Cyt B at a concentration of 
3pg/m l in culture to induce binucleate cells. However more recent data 
(Weissenborn and Streffer, 1991, McMillan and Bush, 1991) has suggested that 
3pg/m l of Cyt B itself can induce increased levels of spontaneous Mn but 
lower concentrations reduced this spontaneous Mn frequency whilst still 
permitting cytokinesis blockage. From Figure 3.2 it can be seen that for 
human uroepithelial cells an optimal working dose of Cyt B was found to be 
3 pg/m l and above since below that cells escape cytokinesis blockage as 
indicated by the reduced Binucleate cell index. Increasing concentrations of 
Cyt B were not found to generate a corresponding increase spontaneous Mn. 
Hence this supports the original findings of Fenech and Morley 1985.
3.8 Relative radiosensitivities of human uroepithelial cells and the
malignant carcinoma cell line T24.
From Figure 3.3 it can be seen that the Mn frequency in binucleate cells 
increased with time following radiation treatment. The results show that the 
SV-HUC lines all had similar chromosomal radiosensitivities as estimated 
from Mn frequencies at 48 hours following X-irradiation (Figure 3.3). The data 
shown in Figures 3.3 & 3.4 indicates that the SV-HUC lines were significantly 
less radiosensitive than the T24 cell line (also of bladder epithelial origin). It is 
possible that the apparent radiosensitivity of T24 cells could be influenced by 
the shorter doubling time of T24 relative to the SV-HUC lines. This will lead 
to a more rapid accumulation of Mn with time, as seen in Figure 3.3 and as 
discussed by Savage (1989). This effect may however, to some extent, be offset 
by the more rapid exit of T24 cells from the binucleate into the quadranucleate
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compartment (unscored cells) as shown in Figure 3.5. Hence comparisons of 
radiation induced Mn frequencies are only made between cells that have 
cycled to the same extent following radiation treatment and are in a similar 
"time window".
Tumourigenic T24 cells are themselves reported to be somewhat 
radioresistant when compared with certain other tumour cell lines (Parris et 
ah, 1988). The expression of the SV40 T-antigen within human fibroblasts has 
also been shown to decrease radiosensitivity (Arlett at ah, 1988). SV-HUC 
lines have been immortalized but are not fully transformed (i.e. non- 
tumourigenic as assayed by inoculation of cells into nude mice; Christian et 
ah, 1987). However, they do contain the SV40 T-antigen, Figure 3.11 and 
Christian et ah, 1987). This lack of a fully transformed phenotype but presence 
of the SV40 T-antigen supports the idea that it is this sequence of viral DNA 
that somehow confers increased radioresistance to the cell.
Due to the difficulty in obtaining a viable single cell suspension of the SV- 
HUC lines colony assays could not be used to determine survival curves 
directly. However, the Mn frequencies as shown in Figure 3.4 indicates an 
almost 2-fold lower induction of Mn in SV-HUC lines than in T24 cells. 
Because of the radioresistant nature of the SV-HUC lines in terms of X-ray 
induced Mn levels, a probable survival curve for the three SV-HUC lines is 
shown by the dotted line in Figure 3.6. This approximate survival curve is 
based on the Mn data from the SV-HUC lines and makes the assumption that 
most X-ray induced Mn will be lethal events (see Table 3.1). This approximate 
survival curve for the SV-HUC lines was calculated using the data in Table
3.1 and then reading the corresponding value of the number of cells without 
Mn against surviving fraction from Figure 3.7 (solid lines). Because the 
spontaneous level of Mn varies with cell line the background or 0 Gray 
radiation dose Mn value has been taken as zero since it is "induced" levels of 
Mn after irradiation that are being examined. 0 Gray was taken as 100%
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survival. Spontaneous Mn values have been subtracted from the data shown 
in Table 3.1 and Figure 3.7. For actual values of spontaneous Mn see Figure 
3.8.
The number of cells containing no Mn and the surviving fraction of cells 
after radiation treatment would not be expected to coincide exactly. This is 
because the induction of acentric fragments is by no means the only lethal 
lesion generated by ionizing radiation and not all acentric fragments are 
necessarily recovered as Mn in binucleate cells. In fact McMillan and Bush 
(1991) have reported that MGH-U1/T24 cells require approximately 1 Mn per 
lethal event as measured by clonogenic assays. However it does provide an 
indirect approximation of cellular survival for cell lines where clonogenic 
assays cannot be used.
3.9 The nature and significance of Mn as chromosomal aberrations in
carcinogenesis.
The spontaneous or background level of Mn in binucleate cells (Figure 3.8) 
gives an indication of the genetic stability for each cell line. Cytogenetic 
instability has already be reported in the cell line SV-HUC-1 by Meisner et al,, 
(1988). Cell line N T ll having an even higher spontaneous Mn level than SV- 
HUC-1, suggests that N T ll cells have a greater genetic instability than the 
other SV-HUC lines.
Whereas X-ray induced Mn are known to be composed almost entirely of 
acentric fragments (Thomson and Perry, 1988; Littlefield et al., 1989) it is not 
known if these spontaneous Mn are the result of acentric fragment formation 
or whole chromosome loss. However work by Meisner et al, (1988) on the 
cell line SV-HUC-1 shows that this genetic instability resulted in 
chromosomal loss and duplications coupled with translocations and a 
reduction in polyploidy as passage number increased. These spontaneous
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genetic changes alone did not result in the generation of a tumourigenic 
phenotype.
The genetic instability shown by two of the SV-HUC lines may allow a 
synergistic effect between this instability and other additional changes such as 
oncogene activation or tumour suppressor gene loss, both of which are 
known to occur by the types of genomic rearrangements mentioned above. 
These additional changes may be necessary stages in the mutistep process of 
carcinogenesis.
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CHAPTER 4
RADIATION AND CHEMICAL CARCINOGEN 
INDUCED TRANSFORMATION OF HUMAN 
UROEPITHELIAL CELLS.
4.1 Abstract
4.2 Introduction.
4.3 Procedure.
Results
4.4 Cytotoxicity of carcinogen treatments.
4.5 Tumour formation following carcinogen treatments.
4.6 Transformation/dense type colony formation following 
carcinogen exposure.
4.7 Growth of transformed/dense type colonies in 0.3% agar. 
Discussion
4.8 Mechanisms of action of carcinogens used.
4.9 Analysis of tumours - development and characteristics.
4.10 Generation of transformed/dense type colonies and their 
possible significance.
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RADIATION AND CHEMICAL 
CARCINOGEN INDUCED 
TRANSFORMATION OF HUMAN 
EPITHELIAL CELLS.
ABSTRACT
4.1
The effects of ionising radiation and chemical carcinogen exposure on 
oncogenic transformation in human epithelial cell lines were examined. The 
criteria used to assess such a phenotype included; tumour formation in nude 
athymic mice, altered morphology in cell culture and reduced anchorage 
dependence in semi-solid media. The SV 40 immortalised epithelial cell lines 
were very resistant to both radiation and chemical induced transformation as 
assayed by tumour formation. Only 1 out of >80 carcinogen treated cultures 
generating a tumour in contrast to 4 out of 5 tumours being produced by the 
inoculation of human bladder carcinoma cells into athymic mice as positive 
controls. Altered morphology was observed in both radiation and chemical 
carcinogen treated cultures held at confluence with a much higher frequency 
than that of tumour formation. Such cultures also showed a strong correlation 
between altered cellular morphology (resembling Transitional Cell Carcinomas 
of the bladder when grown in culture) and an increased colony forming 
efficiency in 0.3% agar. However such cultures did not produce tumours when 
cells were inoculated into suitable host animals. The generation of such a 
phenotype in culture may represent an analogous situation to formation of 
benign papillomas in vivo.
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INTRODUCTION
4.2
As with the earlier work on cellular radiosensitivities a majority of studies 
concerning in vitro radiation induced transformation, have to date, been 
carried out on rodent cell lines (Hall & Hei 1985). An over view of the 
different transformation systems which have previously been employed to 
study radiation induced transformation is given in the main introduction 
(sections 1.2 &1.3).
The generation of a transformed phenotype from cells not exhibiting such a 
phenotype has been measured in several different ways. The formation of a 
tumour after inoculation of cells into athymic nude mice is normally viewed 
as the definitive test for neoplastic transformation, since several different 
human tumour types exhibit the same histopathology in such hosts as they 
do in the original patient (Giovanella et al, 1978). However, this is costly and 
often requires long incubation periods in the animal. Other indicators of 
cellular transformation which can be more rapidly assayed include: 
morphological alterations (Reznikoff et al, 1973a, Reznikoff et al, 1983,
Bryant & Riches 1989), increased colony forming ability in semi-solid media 
(0.3% Agarose; Trent et al, 1990) or even the expression of a known marker of 
transformation for a particular model system such as the alkaline 
phosphatase 75 KDa protein tumour-associated antigen for HeLa x skin 
fibroblasts (Sun et al, 1988).
Certain compounds such as phorbol esters whilst themselves alone are not 
capable of inducing neoplastic transformation can, when coupled with other 
carcinogen treatments, have a synergistic effect and lead to increased 
transformation frequencies (Kennedy et al. 1978). One such agent used in this 
study was TPA (12-0-tetradecanoyl-phorbol-13-acetate).
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The effect of various carcinogen treatments both physical and chemical on 
the cellular transformation of SV40 immortalized human uroepithelial cells 
was studied. The cells used for transformation experiments were primarily 
SV-HUC-1 or PC stock for which transformation using chemicals has already 
been reported (Reznikoff et al, 1988 and Bookland et aL, 1992). The usual end 
point for such experiments was the inoculation of cells into nude mice and 
subsequent checking for the formation of tumours. The effect of 
postconfluence growth inhibition following carcinogen treatment was also 
assayed by the formation of foci or"dense type colonies" and growth 
properties in 0.3% agarose.
PROCEDURE
4.3
The ability of radiation and chemical carcinogens to facilitate neoplastic 
transformation of human uroepithelial cells was assayed by tumour 
formation in nude athymic mice. Cells were exposed to different pre­
determined doses/concentrations of the relevant carcinogen before a 6 - 8  week 
post-carcinogen growth regime. Cultured cells were then sub-cutaneously 
injected into test animals and followed for up to 6  months.
The cytotoxicity of such carcinogen treatments was assayed using a '"grow 
back" technique. A known number of cells were, treated with the carcinogen 
and the cell number determined 96 hours after the end of treatment. Such 
carcinogen treated cultures were compared to control cultures having 
received no carcinogen treatment.
Morphological alterations and increases in anchorage independant growth 
were also studied following carcinogen exposure. Carcinogen treated cultures 
maintained at confluence were screened following staining with Giemsa for
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foci or dense type colony formation. Increased anchorage independant 
growth as determined by the frequency of colony formation in 0.3% agar.
RESULTS
4.4 Cytotoxicity of carcinogen treatments.
The carcinogens used were:- X-irradiation, bleomycin, DMBA, MCA,
MNNG and TPA. The cytotoxicity of these treatments is shown in Figures 
4.1-4.5 and the dose used in transformation experiments indicated by arrows 
at the corresponding concentration/dose. Figure 4.1 shows the cytotoxicity of 
X-rays and agrees closely with the estimated survival curve of SV-HUC lines 
calculated from Mn data in chapter 3. Cytotoxicities of the chemical 
carcinogens Bleomycin, DMBA and MCA were not as great that of MMNG at I
the corresponding concentrations (Figures 4.2-4.6). TPA was found to increase 
cell survival at low concentrations (0 . 0 1  pg/m l and below) but was toxic at the 
higher doses used (Figure 4.6). The mechanisms of action for these mutagens 
will be considered in the discussion.
4.5 Tumour formation following carcinogen treatments.
In only one case did carcinogen treatment of SV40 immortalized human 
uroepithelial cells result in the generation of a tumour after passaging in cell 
culture and inoculation into nude athymic mice. One single dose of 2 Gy X- 
irradiation produced this transformed phenotype. Higher doses and multiple 
doses of radiation, as well as highly mutagenic chemical carcinogen 
treatments failed to produce any transformants as assayed by this technique 
(Tables 4.1 & 4.2).
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FIG 4.1. Cytotoxicity of X-rays (single treatment) on SV-HUC-1 cells. % survival is relative to controls 96 hours after irradiation. Error bars represent data from 3 samples. Arrows indicate the doses used in transformation experiments.
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FIG 4.2. Cytotoxicity of 3-methylcolatherene(MCA; single 48 hour treatment) on SV-HUC-lcells. % survival is relative to controls 96 hours after addition of the carcinogen. Error bars represent data from 3 samples. Arrows indicate the concentrations used in transformation experiments.
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FIG 4.3. Cytotoxicity of 7 ,12-Dimethylbez-anthracine (DMBA; single 24 hour treatment) on SV-HUC-1 cells.% survival is relative to controls 96 hours after addition 
of the carcinogen. Error bars represent data from 3 samples. Arrows indicate the concentrations used in 
transformation experiments.
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FIG 4.4. Cytotoxicity of N-methyl-N-nitrosoguanidine (MNNG; single 24 hour treatment) on SV-HUC-1 cells. % cell survival is relative to controls 96 hours after addition of the carcinogen. Error bars represent data from 3 samples. Arrows indicate the concentrations used in transformation experiments.
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FIG 4.5. Cytotoxicity of Bleomycin (single 24hour 
treatment) on SV-HUC-1 cells. % cell survival is relative to controls 96 hours after the addition of 
the carcinogen. Error bars represent data from 3 samples. Arrows indicate the concentrations used in transformation experiments.
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FIG 4.6. Cytotoxicity of 1 2 -O-tetradecanoylphorbol- 13-acetate (TPA; continuous exposure) on SV-HUC-1 cells. % survival is relative to controls 96 hours after the addition of the drug. Error bars represent data from 3 samples. Arrows indicate the concentrations used in transformation experiments.
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The tumour formed after 2 Gy X-irradiation of SV-HUC-1 cells was biopsied 
after 160 days. Half the biopsy was fixed and sectioned in preparation for 
staining. The other half of the tumour biopsy was minced into 1mm x 1mm 
cubes and placed back into tissue culture. These however did not regenerate a 
cell line and no out growth from tumour explants was observed. The 
sectioned tumour biopsy was stained with haematoxylin and eosin (H & E) to 
enable histological examination (Figure 4.7) showing a small, 
undifferentiated carcinoma containing cords of tumourigenic cells in the 
surrounding stromal tissue. Staining with antibodies against SV40 T-antigen 
(Figure 4.8) and human cytokeratin was also carried out, both of which were 
positive.
Number of tumours 
formed
Number of 
transformation assays 
on SV40 immortalized 
cells using radiation as 
the carcinogen.
54 1
Number of 
transformation assays 
on SV40 immortalized 
cells using chemical 
carcinoens
33 0
Number of bladder 
carcinoma cell line (T24) 
inoculations
5 4
TABLE 4.1. Simple breakdown of tumour formation data from nude 
athymic mice inoculated with human epithelial cells.
Four of the five bladder carcinoma cell line (T24) inoculations into nude 
athymic mice resulted in tumours which were biopsied after 34 days (Figure 
4.9). Sections of biopsied tumours were placed back into tissue culture where 
they generated cell lines which were again found to be tumourigenic when
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TREATMENT NUMBER OF TUMOURS COMMENTS
SV-HUC-1  (PC) cells
Control 0/232Gy X-rays 1 / 8 -«-Small tumour formed4Gy X-rays 0 / 1 0 but failed to generate a
6 Gy X-rays 0 / 6 cell line when tissue2x 4Gy X-rays 0 / 6 biopsy taken and2x 4Gy X-rays+TPA 0 / 6 reintroduced into tissue
MCA(5ng/ml) 0 / 8 culture.
MCA(10ng/ml) 0 / 6
Bleomycin (ljj.g/ml) 0/3
Bleomycin(l |ig/ml)+ 0/3TPAMNNG (0.5tig/ml) 0/3DMBA (5ng/ml)+TPA 0/3Control + TPA 0/3
2x 4Gy yrays+ HAC 0 / 12x MCA(5jig/ml)+ HAC 0/3
8 Gy yrays + HAC 0/3Control HAC* 0 / 6
T24 Bladder carcinoma
cells.
Positive Control 4/5 -«- Large rapidly growingtumours formed whichdid produce cell lines.
SV-HUC (NT 1 1 ) cells
Control 0/32Gy X-rays 0/34Gy X-rays 0/3
6 Gy X-rays 0 / 2MCA (5jug/ml) 0/3
SV-HUC (BC16) cells
Control 0/3
4Gy X-rays 0/3
6 Gy X-rays 0/3MCA (5|rg/ml) 0 / 2
TABLE 4 .2 . Tumour formation data from human epithelial cell 
lines injected s.c. into nude athymic mice. HAC (cultures Held At 
Confluence).
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FIG 4.7. H & E stained section of the tum our generated  
after a single 2 Gy X-ray dose adm inistered to SV-HUC-1 
cells. The sm all tum our m ass can be seen on the left of 
the photom icrograph. C onnective tissue, m ouse ep iderm is  
and hair folicles are also visable in the right half of the 
section. Scale bar represents 0.25mm.
FIG 4.8. M onoclonal antibodies against SV40 T-antigen  
(antibody PAb 405) staining a fixed tum our section  
generated by 2 Gy X-rays on SV-HUC-1 cells (see Figure 4.7). 
Dark brow n areas represent the staining o f cell nuclei 
containing the SV40 T-antigen, i.e. SV40 transform ed cells . 
V isualization  carried out u sin g  DAB (D iam inobenzadine). 
Scale bar repsents 10pm.
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FIG 4.9. Tum our form ed after s.c. inoculation of T24 bladder  
carcinom a cells into a nud e athym ic m ouse. The site of 
tum our form ation is consistant w ith  the site of injection  
(m id w ay betw een  fore and h ind lim bs in lateral position).
T24 carcinoma cells
T24 carcinoma cells
T24 carcinoma cells
10 - T24 carcinoma cells 
SV-HUC-1 cells (2Gy X-rays)
I
-Ot-O-
100 160200 40 60 80
Time in days after inoculation o f cells.
FIG 4.10. Tum our grow th fo llow ing inoculation o f cells 
into nud e athym ic m ice.
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re-introduced into nude mice. It is unclear why only 4 of the 5 inoculated 
animals generated tumours, possibly due to a poor injection
The tumours generated by T24 cells were first observed 9-12 days after 
inoculation into nude mice and grew rapidly in size until they had reached 6- 
12 mm in diameter three weeks later when they were biopsied. The tumour 
generated from SV-HUC-1 cells following 2 Gy radiation took much longer to 
appear, 72 days after inoculation, and grew much more slowly resulting in a 
tumour mass of only 3 mm in diameter after 5 ^ / 2  months in the animal 
(Figure 4.10).
4.6 Transformed/dense type colony formation following carcinogen 
exposure.
'Transformed colonies" resulting from postconfluent growth inhibition 
following carcinogen treatment, were visable in tissue culture flasks even 
prior to staining as areas of high cell density on top of a confluent monolayer. 
Such colonies appeared 6-8 weeks after carcinogen treatment and confluent 
inhibited growth had been attained. However these could be more easily 
identified following fixation and staining of the flask with Giemsa (Figure 
4.11). Such transformed colonies resulted from both radiation and chemical 
exposure in single and double treatment protocols (Table 4.3). This is in 
contrast to control cultures which did not show such morphological 
alterations but remained as a single confluent monolayer (Figures 4.12 - 4.14). 
Figures 4.12a and 4.13a show the typical appearance of non-transformed SV- 
HUC-1 cells at confluence, a small number of mitotic figures are visable in a 
background of non-overlapping "cobble stone" like cells. Figures 4.12b and 
4.13b indicate the appearance of SV-HUC-1 cells at confluence and having 
undergone morphological alteration following carcinogen treatment coupled 
with appropriate culture conditions (see section 2.4 a).
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FIG 4.11. Giemsa stained flask following 2x 4Gy gamma irradiations, 
passaging and maintenance at post confluent inhibited growth for 6 
weeks prior to fixation and staining. The arrows indicate "transformed 
or dense" type colonies in a background of SV-HUC-1 cells.
With the double radiation exposure protocol and one passage between 
treatments, 4 Gray appeared to be an optimal dose for transformation, where 
as with the single exposure protocol followed by no passaging 8 Gray was 
found to be optimal.
Upon transplantation of such colonies to a new tissue culture flask, cells 
only exliibited a limitted outgrowth on the base of the flask. However, such 
colonies did continue to grow by cells piling up so generating a very tight and 
dense colony of considerable mass a further 6-8 weeks after transplanting 
(Figures 4.15-4.17). Some colonies becomes so large that they could be 
removed fixed, sectioned and H & E stained (Figure 4.18). Such sections 
showed a very dense accumulation of cells and cell debris with an active
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FIG 4.11. Giemsa stained flask following 2x 4Gy gamma irradiations, 
passaging and maintenance at post confluent inhibited growth for 6 
weeks prior to fixation and staining. The arrows indicate "transformed 
or dense" type colonies in a background of SV-HUC-1 cells.
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CARCINOGENTREATMENT "TRANSFORMED" PHENOTYPE WHEN HELD AT CONFLUENCE
INCREASED COLONY FORMATION IN 0.3% AGAROSE.
Double exposure protocol
Control 1 — —
Control 2 — —
Control 3
2Gy 7 rays 1 - -
2Gy Yrays2 — —
2Gyyrays3
4Gyyraysl 4* +
4Gyyrays2 — —
4Gy yrays3 + (Fixed & stained) ND
6Gy y rays 1 — -
6Gyyrays2 - —
6Gy y rays 3 -
MCA 5pg/ml 1 +MCA 5pg/ml 2 + +MCA 5pg/ml 3 + +
Single exposure protocol
Control 1Control 2Control3
2Gyyraysl - -
2Gyyrays2
2Gyyrays3
4Gy yrays 1 - —
4Gy y rays 2 — —
4Gy y rays 3
8Gy y rays 1 + +
8Gyyrays 2 +
8Gyyrays3 + +
TABLE 4.3. 'Transformed" colony generation data from SV-HUC-1 cultures held at post confluent inhibited growth for 6 weeks following carcinogen exposure. Double carcinogen exposure transformation experiments were performed with one passage between treatments. No passaging was carried out in single carcinogen exposure experiments. ND - Not determined.
FIG 4.12a. Phase contrast photomicrograph of normal, non- transformed SV- 
HUC-1 cells having obtained confluence. Cells maintain a "cobble stone" 
appearance and no piling up of cells is evident.
FIG 4.12b. Phase contrast photomicrograph of SV-HUC-1 cells from a 
transformed or dense type colony. Cells have changed their morphology and 
are more spindle like in appearance with cells now growing one on top of 
another i.e nolonger exhibiting contact inhibition.
FIG 4.13a. Photomicrograph of Giemsa stained normal confluent SV-HUC-1 
cells again exhibiting a "cobble stone" appearance.
FIG 4.13b. Photomicrograph of Giemsa stained cells from a transformed 
colony. Cells are more spindle like in appearance and considerable piling up 
of cells is evident in the bottom of the frame.
All sacle bars represent 100pm.
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FIG 4.14. Photom icrograph of Giem sa stained cells from the junction betw een  
transform ed cells (left) and non transform ed cells (right). P iling up of cells is 
visable w ithin  the the transform ed area o f grow th and the non-transform ed  
area o f cells still sh ow s the "cobble stone" appearance. The arrows indicate tlie 
boundary betw een transform ed and non-transform ed cell types w here there is a 
clear dem arkation point, i.e. The tw o cell populations do not appear to m ix w ith
each other. Scale bar 100pm.
FIG 4.15. Phase contrast photom icrograph of a transplanted transformed colony. 
C ells continue to p ile up w hilst grow ing so  generating a very dense, tight 
colony. Sacle bar 100pm
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FIG 4.16. Phase contrast photomicrograph from the edge of a 
transplanted transformed colony. The dense transformed phenotype 
can be seen on top of non-transformed "cobble stone" shaped cells. 
These non-transformed cells were probably transfered along with 
transformed cells when transplantation took place.
FIG 4.17. Gross overall appearance of transplanted transformed 
colonies growing on the base of a 25cm^ tissue culture flask, 
approximately 8 weeks after transplantation.
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margin of cell growth along the periphery of the colony. These colonies could 
be picked off and inoculated into nude mice as a solid mass of cells and 
checked for tumour formation.
Alternatively the initial flask exhibiting the transformed phenotype could 
be treated with EDTA/trypsin to remove cells and inoculations carried out as 
described previously. However no tumours were observed in any animals 
receiving cells from such transformed colonies. If transplatation into the 
mouse was from as a solid mass then a small lump persisted for 2-3 weeks 
before readsorption by the animal.
4.7 Growth of transformed/dense type colonies in 0.3% agar.
When cells were removed from cultures exhibiting a transformed or dense 
type colony, growth in semi-solid media (0.3% agar) was also examined. The 
EDTA/trypsin treatment generated close to a single cell suspension suitable 
for colony assays with low plating efficiency. Controls were non-carcinogen 
treated cultures held at confluence which did not show dense type colony 
formation. Only colonies greater than 50 cells were scored (Figure 4.19). In all 
cases where dense type colony formation had been observed in cultures 
maintained at confluence, there was a corresponding increase in colony 
formation above that of control samples (with the exception of one MCA 
treated culture; see Table 4.4).
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FIG 4.18. H & E stained section of a transformed/dense type colony
generated by a single 4 Gy y radiation treatment of SV-HUC-1 cells, 
eight weeks after transplantation into a new culture flask. There is a 
dense accumalation of cells which nolonger show the "cobble stone" 
morphology of the parental cell type. Scale bar 500pm.
FIG 4.19. A phase contrast photomicrograph of a colony of SV-HUC-1 
cells growing in 0.3% agarose with Hams F12+ 1% PCS medium after 
a 21 day incubation period. A background of surrounding single cells
which did not generate colonies can also be seen. Scale bar 100pm
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Treatment Colony Forming Efficiency xlO*4
Standard Error of Mean
Control 1 1.13 1.08Control 2 1.69 0.56Control 3 1.75 0.34
2xMCAl1 t 1.53 0.372xMCA2 t 4.79’* 0.142xMCA3 t 4.33* 0.37
2x4 Gy yrays t 6.22* 0.31
2 Gy y rays 1 1.30 0.59
2 Gy y rays 2 2.40 0.23
4 Gy Y rays 1 2.19 0.59
4 Gy yrays 2 2.63 0.91
4 Gy y rays 3 2.07 0.45
8 Gy y rays 1 t 6.03* 2.21
8 Gy y rays 2 t 7.53* 0.82
8 Gy yrays 3 t 11.68* 1.21
Table 4.4. Colony forming effeciency in 0.3% Agar. Data represents mean values from triplicate platings. * denotes a significant difference from control samples (student’s t -test), t  indicates cultures which formed dense type colonies 
when maintained at confluence.
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DISCUSSION
4.8 Mechanisms of action of carcinogens used.
X-rays and other forms of ionizing radiation as with all carcinogens, 
achieve a mutagenic effect by direct or indirect interaction with nuclear 
DNA. In the case of ionizing radiation this is often via the induction of 
highly reactive free radicals, two thirds of X-ray damage to DNA is estimated 
to be caused by OH* radicals (Hall 1988, Schans et aL, 1982). Base modification 
and rupture of the phosphodiester backbone in the DNA molecule via single 
& double strand breaks and other local multiple damaged sites have all been 
shown to result following treatment of mammalian cells with ionizing 
radiations (reviewed by Ward 1986, Teoule 1987). As with all carcinogens it 
is the non-repair or misrepair of subiethal damage within cells that leads to 
the fixation of such genetic alterations, mutations and possible oncogenic 
activation (Elkind 1984, Hanawalt et al., 1979). Due to the nature of certain 
types of damage i.e. chain rupture, a large fraction of radiation induced DNA 
damage will be manifested as deletions rather than single base substitutions 
of the type induced by many chemical carcinogens. Hence these changes 
tend to be of a more lethal nature and not as oncogenic as many potent 
chemical carcinogens (Harris 1991).
Bleomycin a radiomimetic drug also damages DNA by free radical 
mechanisms and has a reported mutational sepectrum similar to that of X- 
rays (Povirk & Goldburg 1987). DMBA (7,12- Dimethylbenzanthradne) 
known to be a potent carcinogen for over 40 years, causes primarily A:T->
T:A transversions (Harris 1991). The mechanism of action for MCA (3 
Methylcholatherene) is not clearly known (Reznikoff et at., 1998). MNNG 
(N-methyl-N-nitrosoguanidine) is an alkylating agent which induces a large 
number of O^-methylguanosine residues so causing mispairing with
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thymine during DNA synthesis (Bridges & Lehmann 1982). TPA (12-0- 
tetradecanoylphorbol-13-acetate) a phorbol ester is a tumour promotor and 
has been shown to enhance the transformation frequency of mammalian 
cells following radiation treatment (Kennedy et al. 1978). This is probably 
due to an increased cell saturation density being obtained. TPA is reported to 
interfer with cell-to-cell communication, recent work suggests this is 
mediated by activation of protein kinases (such as protein kinase C), so 
leading to further phosphorylation of proteins which act as growth/cell cycle 
control regulators (Meek and Street 1992, Tauchi et aL 1992).
4.9 Analysis of tumours - development and characteristics.
Inoculation of control cells (unirradiated or no carcinogen tratment) into 
nude mice shows that these immoralized human epithelial cells are non- 
tumourigenic (0 tumours out of > 25 inoculations into host animals). This 
agrees with work previously reported by Christian et ah, 1987.
The low transformation frequency after both radiation and chemical 
carcinogen treatments (1 out of > 80 carcinogen exposure experiments 
generating a tumour in host animals) indicates that these human cell lines 
are very resistant to full oncogenic transformation. The generation of a 
tumourigenic phenotype by chemical carcinogens (MCA and 4- 
Aminobiphenyl) which have been reported by Reznikoff et aL, 1987 and 
Bookland et aL, 1992 using the above cell line (SV-HUC-1), could not be 
demonstrated here. The enhanced transformation frequency shown by the 
synergistic effects of TPA and carcinogen treatment as reported in rodent cell 
lines ( Kennedy et aL, 1978, Elkind et aL, 1985) was also not evident in such 
experiments. This is not entirely surprizing considering the very low  
number of transformants obtained and also in the view of the evidence that 
TPA obtains its effect by increasing saturation densities, since the 
experimental protocol used did not allow cultures to reach
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saturation/confluence. Due to the low number of transformants generated 
by chemical or physical agents as assayed by tumour formation using SV- 
HUC lines, the calculation of any transformation freqencies or risk 
assesments was not possible.
The staining of the radiation induced tumour with antibodies to SV40 T- 
antigen and human cytokeratin indicated that the tumour obtained was of 
human epithelial origin and from cells immortalized by SV40 virus, i.e. 
derived from the SV-HUC-1 parent cell line and not a contaminant or 
spontaneous mouse neoplasm.
There was a long incubation time in vivo before manifestation of the 
tumour coupled with a slow and indolent growth pattern i.e. producing a 
tumour of small diameter which neither progressed or regressed. This 
suggests the generation of a non-aggresive tumour phenotype after the 
inoculation of a relatively small number of transformed cells in the initial 
inoculum when compared to the carcinoma cell line T24. Unfortunately, 
biopsy explants of this tumour did not generate a cell lines in tissue culture 
so limiting the characterization of the transformants to fixed material. This 
inablity to produce a cell line after tumour explantation from a suitable host 
animal has also been reported by Craise et al, 1991 after irradiation of 
immortalized but nontumourigenic human kératinocytes (using multiple 
radiation treatments and an in vitro protocol of >  1 year in tissue culture). 
However full onocgenic transformation of human epidermal kératinocytes 
including the regeneration of a cell line from tumour biopsies has now been 
reported (Thraves at a l, 1990).
4.10 Generation of transformed/dense type colonies and their possible 
significance.
The transformed or dense type colonies formed after carcinogen treatment 
in SV-HUC cultures which were allowed to remain in a state of post
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confluence inhibited growth, share some similarity to the colonies formed in 
rodent systems eg. IOTVz* Although these transformed colonies do not 
produce tumours when inoculated into suitable host animals the 
morphology of these transplanted transformed colonies i.e. into new tissue 
culture flasks, resembles closely that shown by transitional cells carcinomas 
(TCC's) of the urinary bladder when growing in tissue culture (Reznikoff et 
al, 1986b).
These "transformed" colonies whilst not showing full oncogenic 
transformation (i.e. tumour formation) probably represents the generation of 
a phenotype similar to a benign papilloma in in vivo studies, although 
progression from this state to a more aggressive/oncogenic phenotype was 
not studied here. The progession from an indolent in vivo phenotype in 
nude mice using SV-HUC-1 cells to a more aggressive, rapid growing, 
neoplastic phenotype has been reported by Wu et al (1991). This resulted 
after combined chemical carcinogen treatments with MCA initially and 
subsequently N-hydroxy-4-acetylaminobiphenyl. In this present study there 
was also a corresponding increase in colony formation in 0.3% agarose for 
cultures exhibiting transformed/dense type colonies (except one MCA 
culture). This supports the suggestion of a "transformed" phenotype, 
evidence provided by both an altered morphology and a reduced anchorage 
dependence in such cultures.
The single dose of 8 Gy radiation that produced transformed colonies will 
have had a lethal effect on a large fraction of the initial irradiated 
population. This means that whilst no passaging was carried out, the 
surviving fraction will have undergone a considerable amount of "grow 
back" going through many cell doublings before reaching confluence and 
growth inhibition. Conversly with the double exposure protocol 4Gy 
appeared to be optimal for induced transformation. However, passaging was
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performed so allowing all surviving irradiated cells to progress through 
several cell doublings before confluence was attained.
Several factors influencing the frequency of radiation induced oncogenic 
transformation of rodent lOT^/z cells have been reported. These include 
dose rate, if fractionation of the dose was administered, cell density (both 
initial and confluent, which can be altered by agents such as TPA) and linear 
energy transfer (LET) of the radiation given (reviewed by Elkind et ah, 1985). 
More recent evidence also indicates that the phase of the cell cycle when the 
irradiation is carried out may be important, G2 appearing as a sensitive 
window for oncogenic transformation (Cao et al. 1992, Miller et al. 1992).
Although such a diverse range of different conditions was not examined 
here, it appears that the generation of a transformed phenotype in radiation 
induced transformation studies using SV-HUC cultures depends strongly on 
the ability of cells to undergo several cell divisions before reaching post 
confluent inhibited growth.
This need for cell division following radiation treatment may reflect a 
fixation of cellular damage and a proliferation of "initiated" but not yet 
transformed cells. A selection pressure must then be applied if these 
"initiated" or altered cells are to proliferate relative to surrounding cells. In 
cultures maintained at or near optimal growth conditions there is little 
chance for a selective pressure to be applied since all cells are proliferating at 
or close to a maximal rate. The maintainence of NIH 3T3 mouse cells at low 
cell density in high serum conditions (i.e. optimal growth conditions) has 
been shown to reduce transformation frequencies (Yao et al., 1990). Also 
reduction/removal of serum in human keratinocyte cultures has been 
shown to increase transformation (Hill & Hillova 1990). However, if 
cultures are maintained at confluence then reductions in growth contact 
inhibition and other selective growth advantages can be visualized by colony 
formation, i.e. proliferation relative to surrounding cells. This is also more
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analogous to cancer formation in vivo where cells are kept in check by their 
position within a tissue and relative to surrounding cells, thus aberrant 
growth relative to other more strictly controlled cells constitutes the 
generation of a neoplasm. Hence growth conditions that constrain rather 
than encourage multiplication of already initiated cells may lead to the 
increased detection of transformed phenotypes in vitro.
"Thus, growth stimulation in vivo and growth inhibition in vitro may 
converge on the optimal conditions for transformation" Faber and Rubin 
1991.
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ABSTRACT
5.1
Mutations in the p53 gene which lead to the expression of mutant protein 
sharing a common conformational effect, have been identified as the most 
frequent genetic alterations in human cancer. Until recently however, the 
normal cellular function and mechanism of activation of wild type p53 has 
remained unclear.
Changes in the level of wild type (wt) p53 protein following irradiation was 
assessed in three human epithelial cell lines from different origins. As a 
result of treatment with ionizing radiation one cell line HPV (human 
papilloma virus transformed) exhibited an approximate two fold increase in 
p53 levels. This induction of wt p53 protein could be achieved with relatively 
low doses of gamma radiation (1 Gray). The induction of p53 in other cell 
lines following irradiation could not be detected with increasing doses of 
radiation nor with extended sampling times.
Again only cell line HPV showed any form of cell cycle delay following 
irradiation with cells accumulating in G2 and not Gi. This result suggests 
that the E6 protein of the human papilloma virus is not capable of blocking 
the induction of wt p53 following irradiation although its function may be 
modified or abrogated, i.e. a Gl arrest is not observed.
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INTRODUCTION
5.2
Mutations in the gene coding for the 393 amino acid nuclear phosphoprotein 
p53 are the most frequently observed genetic alterations so far identified in 
human cancer (Vogelstein 1990). The p53 gene located on chromosome 17pl3.1, 
now termed a tumour suppressor gene (genes for which loss-of -function 
mutations result in oncogenic transformation), largely due to the initial 
observation that this gene is mutated or deleted in 70-80% of colorectal 
carcinomas (Baker et al, 1989). However, alterations of the p53 gene have now  
been identified in a wide range of human cancers including:- breast, bladder, 
brain, colon, lung, ovarian and prostate neoplasms (Nigro et a l 1989, Isaacs et al 
1991, Jones et a l 1991 and Eccles et al).
The p53 protein was first identified bound to the large T-antigen of SV40 
transformed cells (Lane and Crawford 1979). More recently the wild type p53 
protein (wt p53) has also been found to bind proteins from several other viruses 
such as adenovirus and human papilloma virus (Werness at al 1990, Yew and 
Berk 1992). This association with viral proteins appears to alter the DNA 
sequence specific binding of wt p53 in a similar way that the MDM2 protein 
does. The MDM2 gene is often found amplified in human sarcomas where no 
p53 mutations have been observed and codes for a protein which binds wt p53 
(Oliner et al 1992). Hence this protein may be a normal human cellular counter 
part acting in a similar way to the DNA tumour virus oncoproteins.
The mutant p53 proteins have a much longer half life (4-8 hours) than that of 
the wild type (6-20 min; Lane and BencMmol 1990) so leading to the 
accumulation of the mutant protein in transformed cells (Levine et a l 1991). A 
wide range of point mutations within the p53 gene have been identified that are 
capable of facilitating oncogenic transformation, however all such mutations 
produce a common conformational change within the protein (Gannon et al 
1990). Cells expressing mutant p53 protein or cells that contain no endogenous
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p53 protein due to the complete deletion of this gene, can have an oncogenic 
phenotype suppressed by the transfection of a wild type cDNA copy (Chen et al. 
1990). Further evidence as to the involvement of mutant p53 in the generation 
of human neoplasia came from families affected by Li-Fraumeni syndrome, who 
show a high incidence of tumour formation in a variety of different organs. 
Germline p53 mutations have been identified in such patients who already 
contain one wild type and one mutant p53 allele (Wienberg 1991). Hence 
mutation or loss of the one remaining wild type allele is a far more likely event 
than loss/mutation of two alleles in individuals not affected by this syndrome.
How then can the p53 protein play such an important role in carcinogenesis?
The inhibition of mammalian cell cycling by radiation induced DNA damage 
has been well documented (Little 1968, Painter and Young 1980, Kilmer et al.
1981, Zampetti-Bosseler et al. 1981). This mitotic delay/inhibition of DNA 
synthesis appears to allow an increased repair of damaged DNA prior to 
progression through the cell cycle and so reduce the chance of fixing damaged 
DNA at S-phase or mitosis which could generate mutation. Ultraviolet 
irradiation of mouse 3T3 cells (Maltzman and Czyzyk 1984) and X-irradiation of 
human haematopoietic progenitor cells (Kastan et al. 1991) have been reported 
to show a corresponding increase in wt p53 levels with a cell cycle delay 
occuring predominantly at Gi. More recently Kuerbitz et al. (1992) have shown 
that cell lines expressing mutant p53 fail to arrest at G% following y irradiation.
The wild type p53 protein is thought to be a transcription factor binding to 
specific DNA sequences as a tetrameric complex which modulates the 
transcription of downstream genes controlling cell cycle determining factors 
(Lane 1992a, Lane 1992b). Wt p53 is stabilized by a post-translational 
mechanism which is induced by damaged DNA, This causes an alteration in the 
level/activity of the cell cycle determinant(s) so leading to an increased cell 
cycle delay and time for repair of damaged DNA. If successful repair is not 
carried out then wild type p53 has the ability to induce apoptosis (Yonish et al.
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1991, Ryan et al, 1993). Both these strategies employed by the cell ensure tliat 
clones with mutations do not survive and so act as a source of future neoplastic 
or preneoplastic cells. Since the genome of any cell is constantly at risk from 
mutations both spontaneous and induced, a mechanism which keeps a check on 
the fidelity of the genome is of vital importance. Hence individuals who lack 
such a process leave their cells open to a much greater risk of accumulating 
potential oncogenic genomic alterations.
Linked to these observations is a "dominant negative" model of tumour 
suppressor gene inactivation (reviewed by Oren 1992). When one p53 allele 
becomes mutated the protein produced from that gene undergoes a 
conformational change and ceases to function as the wild type protein does. 
However in this situation protein of both wild type and mutant conformation is 
present, this may lead to an increased proliferative advantage for such cells so 
generating a large pre-neoplastic subpopulation from which only one wild type 
p53 allele has to be lost or mutated in order that full oncogenic transformation 
take place. Such a model can be further explained by the observation that 
mutant p53 protein binds to the wild type (Levine et al, 1991) so rendering it 
physiologically inactive. This leads to a sharp decrease in the level of 
functionally active wt p53 since the protein in its mutant conformation is far 
more stable than that of the wild type. In such cells there will be very low levels 
of wt p53 that is not bound to the mutant protein, hence the growth advantage. 
However, there will be enough residual wild type fuction to inhibit full 
oncogenic transformation until the loss or mutation of the second p53 allele. 
Although this model is not without its limitations, it does serve to help explain 
some, if not all the observations concerning mutant, wild type or complete lack 
of p53, both at the genetic and biochemical level.
Since a vast majority of adult human tumours originate in epithelial tissues 
(Cairns 1975) the role of p53 after DNA damage in such cells types may well 
play an important part in the development of many human cancers. The
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induction of wild type p53 protein in three human epithelial cell lines of 
different origins (SV40 transformed, human papilloma virus transformed and a 
carcinoma cell line) was studied following treatment with y radiation. Cell cycle 
delay was also examined in order to assess the relationship between wt p53 
induction and cell cycle changes in human epithelial cells following radiation 
induced DNA damage.
PROCEDURE
5.3
Levels of wild type p53 protein in different human epithelial cell lines was 
analysed using ELISA tests with antibody DO-1 as the primary specific 
antibody. The presence of mutant p53 protein was determined by 
immunoprécipitation by antibody PAb240 which is specfic for mutant forms of 
p53. Following irradiation of exponentially growing cells changes in the level of 
wt p53 were examined also using ELISA tests.
Immunostaining of irradiated and unirradiated samples using HRP and FTTC 
detection techniques were also performed. This was coupled with light and 
laser confocal microscopy respectively to indicate the location of wt p53 protein 
within the cell.
Cell cycle changes following irradiation of cultures were analysed using flow 
cytometry after staining with appropriate DNA dyes/uptake of base analogues.
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RESULTS
5.4 Expression of wild type and mutant p53 protein in unirradiated cells
The SV40 immortalized cell line SV-HUC-1, BC16 & N T ll showed a 
charachteristic high level of wt p53 due to its interaction and stablization with the 
SV40 T-antigen (Lane and Crawford 1979). The human papilloma virus 
immortalized cell line HPV and the carcinoma cell line T24 both expressed low  
but detectable levels of wt p53 (Figure 5.1). The staining pattern of wt p53 within 
unirradiated cells is also shown in Figures 5.3a, 5.3b, 5.8a and 5.8b showing strong 
nuclear staining of the nucleus in SV-HUC-1 cells and HPV cells exhibiting no 
nuclear but slight cytoplasmic staining.
Immunoprécipitation of p53 proteins (Figure 5.2) showed that aU SV-HUC lines 
gave a positive result for p53 in both the wild type and mutant conformations 
(antibodies DO-1 and PAb 240 respectively). However since DO-1 recognises 
both mutant and wild type p53 protein, any cell line expessing mutant p53 
protein as determined by positive PAb 240 immunoprécipitation will 
automatically be positive for DO-1 aswell. The Human Osteosarcoma cell line 
HOS also gave a positive result for mutant p53. This cell line was used as a 
positive control, having a known p53 piont mutation of an Arginine to Proline 
change at codon 152 (Romano et al, 1989),
Cell lines T24 and HPV were negative for mutant p53 protein. HTori- cells 
(Human Thyroid Epithelial Cells immortalized by SV40 virus; Lemoine et a l,
1989) gave a positive result with respect to the wild type p53 due to the 
stabilization of p53 by the T-antigen. However, these cells were negative for 
mutant p53. HTori(T) denotes a tumour cell line generated after irradiation of the 
parent cell line. Lanes probed with Anti-Rb antibody IF8 stained negative, 
indicating no non-specific binding by CM-1 serum (anti-p53 antibodies). The
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FIG 5.1 Two site immunoassay with epithelial cell extracts using DO-1 
as coating antibody to detect wild type p53 protein. Plates were 
probed with rabbit anti-p53 serum CMl. Optical density at 450nm is 
proportional to the amount of bound antibody and hence p53. Data is 
representative of three repeat experiments.
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FIG. 5.2a.
Figures 5.2a & 5.2b. Immunostaining of a Western Blot containing 
p53 proteins immunoprecipitated by antibodies DO-1 (wild type and 
mutant conformation), PAb 240 (mutant only) or Anti-Rb (irrelevant 
antibody). Blots were probed with anti-p53 serum (CMl) and 
visualized using HPR conjugated swine anti-rabbit immunoglobulins. 
Cell lines are listed on the right hand side. Molecular weights of the 
proteins are given at the top of the blot. * Protein G.
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FIG 5.3 Immunoperoxidase staining with DO-1 as the primary 
antibody and a rabbit anti-mouse HRP conjugate as the secondary 
antibody to detect wt p53 protein.
a SV-HUC-1 cells showing strong nuclear staining, b HPV cells 
exhibiting no nuclear but slight cytoplasmic staining. Cells to the 
right of the frame represent a negative control (i.e. primary antibody
omitted). Scale bars represent 100pm.
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band at 30,000 Daltons is due to protein G which was used to couple the 
antibody-p53 protein complex,
5.5 Expression of wild type p53 protein in irradiated cells.
Only one cell line HPV showed a increase in wt p53 protein levels following a 
single 2 Gy Y radiation dose, rising rapidly within six hours of irradiation and 
remaining elevated for 48 hours (greatest sampling time used), exhibiting a 
maximal two fold increase in optical density (Figure 5.5). Cell lines SV-HUC-1 
and T24 did not show any increase in p53 protein levels at any of the post 
irradiated sampling times (2 to 48 hours; Figures 5.4 and 5.5). Similarly only in 
cell line HPV did increasing doses of y radiation produce an increase in wt p53 
expression up to 4 Gy and falling slightly at 10 Gy. Increased expression of wt 
p53 above control/unirradiated samples was observed even at the lowest doses 
used (1 Gy; Figure 5.7). Again cell lines SV-HUC-1 and T24 did not show any 
similar corresponding increase in wt p53 protein levels following increased 
radiation doses. This lack of any inducible p53 protein expression by radiation 
treatment in SV40 immortalized human epithelial cells is consistent with previous 
reports of a similar lack of response in SV40 transformed mouse fibroblasts 
following treatment with the U.V. mimetic 4-nitroquinoline-l-oxide (Maltzman 
and Czyzyk, 1984). Due to the high levels of T-antigen bound wild type p53 
protein present in SV-HUC-1 cells no significant increase in p53 was observed 
following Y irradiation.
Following radiation treatment p53 protein could also be detected in the nuclei 
of HPV cells by immunochemical staining with antibody DO-1 when compared to 
unirradiated cells (Figures 5.8c and 5.8b respectively). Not all irradiated HPV 
cells showed such a pattern of p53 protein induction within the nucleus, this may 
reflect cell cycle differences or differing extents of DNA damage within the HPV
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FIG. 5.4 Two site immunoassay with SV-HUC-1 cell extracts using 
DO-1 as coating antibody. All cultures received a 2 Gy y radiation 
treatment prior to the generation of cell extracts at the sampling times 
indicated. Plates probed with CMl serum. Data is representative of 
two repeat experiments.
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FIG 5.5 Two site immunoassay with HPV 6 and T24 cell extracts using 
DO-1 as coating antibody. All cultures received a 2 Gy y radiation 
treatment prior to the generation of cell extracts at the sampling times 
indicated. Plates probed with CM l serum. Data is representative of two 
repeat experiments.
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FIG 5.6 T w o site im m unoassay w ith SV-HUC -1 cell extracts using  
DO-1 as coating antibody. A ll cultures were sampled six hours after 
radiation treatm ent Plates were probed w ith CM l serum. Data is  
representative o f three repeat experim ents.
0.3 HPV
T24
£ 0.2 CSI
«
§ 0.1
0.0 1084 60 2
Radiation Dose in Gray
FIG 5.7 T w o site im m unoassay w ith HPV and T24 cell extracts using DO-1 
as coating antibody. A ll cultures were sam pled six hours after radiation  
treatment. Plates w ere probe w ith  CM-1 serum. Data is representative of 
three repeat experim ents
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FIG 5.8 a
FIG 5.8 Immunochemical staining of wild type p53 protein with 
DO-1 antibodies in a. control (no irradiation) SV-HUC-1 cells: 
strong nuclear staining. Scale bar represents 100 microns b. control 
HPV cells: no nuclear but limited cytoplasmic staining. Scale bar 25 
microns c. HPV cells 6 hours following a 2 Gy y radiation treatment: 
showing localised nuclear staining. Scale bar 25 microns. Visulization 
was with FITC conjugated sheep anti-mouse immunoglobulins and 
viewed by a confocal laser scanning microscope, laser wavelength 
488nm.
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FIG 5.8 b
FIG 5.8 c
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cell population following radiation tratment. No HPV cells exhibited the same 
intensity of staining as SV-HUC-1 cell nuclei (Figure 5.8a).
5.6. Cell cycle changes following irradiation.
Both single channel staining with propidium iodide and double channel 
staining using both propidium iodide and FITC conjugated antibodies in 
conjunction with BrdU uptake, were utilized to study cell cycle changes (Figures 
5.9). However only single channel staining provided data which could be 
meanigfully interpreted. This was for two reasons ; a. incomplete separation of 
the different cell populations b. inability of the FACScan softwear to fit an 
appropriate model to the data generated. Therfore only the results of single 
channel staining will be shown.
Cell cycle changes are shown in Figures 5.10 and 5.11 for all cell lines used. 
However, the results shown in Figure 5.11 represent the computer's 
interpretation of data assimilated using the FACScan. From Figure 5.10 it can be 
seen that there was a considerable disparity between actual data (solid line) and 
model/theoretical data (dotted line) for certain radiation treatments. Therefore 
the data represented in Figure 5.11 should only be treated as approximate values.
None of the cell lines studied showed a significant accumulation of cells in the 
Gi compartment compared to control samples following different radiation doses 
(Figsures 5.11a, b, c). Only the HPV cells exhibited either a Gi or G2  delay 
following radiation treatment with an increasing proportion of cells accumulating 
in the G2 /M  compartment following increasing radiation doses up to 4 Gy and 
falling slightly at lOGy. The proportion of cells in Gi fell in all cell lines following 
radiation treatment. Hence, of the three human epithelial lines studied only cell 
line HPV appeared to have a functioning cell cycle delay mechanism following 
radiation damage which arrests cells predominantly at G2  and not G%.
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FIG. 5.9a. Dot plot of a cell cycle profile from unirradiated SV-HUC-1 cells 
using dual channel staining and analysed on a Fluorescence Activated Cell 
Scanner (FACScan). Note the incomplete separation of the G| and S phase 
components. Pl-Propidium Iodide. FITC/BrdU- Fluorscein Isothiocyanate 
/  5-Bromo-2-deoxyuridine.
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FIG. 5.9b. Dot plot of a cell cycle profile from unirradiated SV-HUC-1 cells 
using single channel staining and analysed on a FACScan. Data of this type 
could be successfully analysed using the softwear available on the FACScan. 
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FIG. 5.10a. Cell cycle changes 
in SV-HUC-1 cells 10 hours 
following various doses of 
y radiation. The solid line 
represents actual data collected 
and the dotted line the 
computers closest model data 
set.
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FIG. 5.10c, Cell cycle changes 
in HPV cells 10 hours 
following various doses of 
7  radiation.
FSC
PI
1 Gray
2 Gray
4 Gray
10 Gray
FL2
I N D U C T I O N  O F  p 5 3  1 0 5
eoi
60- G1
4 0 -IU 30-
2 0 -
G2/M
6 8 102 40
Radiation dose (Gray)
FIG 5.11a. Cell cycle distribution data for SV-HUC-1 cells 
determined using flow cytometric analysis. Cultures were 
sampled 10 hours following radiation treatment.
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FIG 5.11b. Cell cycle ditribution data for HPV cells. Cultures 
were sampled 10 hours following radiation treatment.
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FIG. 5.11c. Cell cycle distribution data for T24 cells. Cultures 
were sampled 10 hours following radiation treatment.
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5.7 The effects of viral oncoproteins on cellular immortalisation and p53.
Immortalisation of human epithelial cells is usually achieved by infection 
of tissue explants with DNA tumour viruses, or by transfection with vectors 
containing sequences derived from tumour viruses (Christian et ai, 1988, 
DiPaolo et a/., 1989, Thraves et fl/.,1990). Both these techniques leave the 
now immortal cell with oncoproteins that bind or interact with the the wild 
type p53 protein (Lane and Crawford 1979, Werness et al., 1990, Scheffner et 
al,  1990, Bargontti et al, 1991, Yew and Berk 1992).
Cell lines HPV and T24 both contain levels of wild type p53 protein 
similar to that expressed in other normal (nontransformed, noncancerous) 
human tissues as measured by similar ELISA tests using DO-1 antibody 
(Barnes et al, 1992). Hence both HPV and T24 cells must contain at least one 
functioning copy of the wild type p53 gene since they are not without any p53 
of the wild type conformation. Also HPV cells do not appear to have their 
p53 protein degraded by the E6 oncoprotein of the human papilloma virus, 
which has been reported to interact with and break down wild type p53 in 
vivo (Mietz et at., 1992). However, it is probable that the transforming/ 
immortalising ability of human papilloma virus E6 protein, SV40 T-antigen 
and adenovirus ElB protein is linked to their ability to modulate p53- 
mediated transcriptional activation (Lechner et al, 1992, Mietz et al, 1992, 
Yew and Berk 1992 and Bartek et al., 1993).
SV-HUC lines immortalised with SV40 gave a positive result with 
antibody DO-1 which detects both mutant and wild type p53 due to the 
stabilisation of p53 by the T-antigen. However, a positive result was also 
obtained with antibody PAb 240 (Figure 5.2) which detects mutant p53 and
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does not recognise p53 when complexed to SV40 T-antigen since the epitope 
needed for binding of this antibody to the protein is then concealed (amino 
acids 156-214; Gannon et al., 1990). This phenomenon is not solely as a result 
of immortalisation by the SV40 T-antigen, HTori- cells also immortalised 
using a plasmid construct of SV40 containing the T-antigen did 
immunoprecipitate with DO-1 but not PAb 240 antibodies i.e. they contain 
stabilized wt but not mutant p53 protein. Therefore two possible 
explanations can be proposed to account for the results obtained, a. Two 
distinct populations of p53 protein; One wild type in nature which binds to 
the T-antigen and is stabilized, the other consisting of mutant protein which 
due to the presence of the mutation is also stabilized, b. That only mutant 
p53 is present but this is unlikely since the cells are known to be non- 
tumourigenic (see Table 4.2) and very few species of mutant p53 bind to SV40 
T-antigen (Bartek et al, 1993).
All SV-HUC lines are in fact sub-clones of different infection/transfection 
experiments using the same individual's uretral tissue. If this individual 
was in fact heterozygous for p53, or alternatively if during subsequent 
passaging following infection/transfection a mutation in one p53 allele 
resulted, then this too could account for the results observed. The situation 
is also complicated by the observation that SV-HUC lines are pseudo-diploid. 
That is they contain a bi-modal karyotype distribution, most cells being near 
diploid and the rest being near tetraploid (Christian et al, 1988, also see 
section A.4). A single p53 mutation in one of four possible chromosome 17's 
would make interpretation of the data difficult. Fortunately the effect of 
mutant p53 or wt p53 bound to SV40 T-antigen is reported to be the same in 
terms of cell cycle arrest/delay following DNA damage i.e. it is abrogated 
(Kastan et al, 1991, Oren 1992).
%1
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5.8. Extended sampling time to monitor cell cycle changes.
The sampling time used to determine cell cycle changes following 
radiation treatment was 10 hours, 4 hours after the maximal induction of 
p53 in HPV cells following a single 2 Gy y radiation treatment (Figure 5.5). 
Kuerbitz el al  (1991) have proposed that p53 is a specific transcription factor 
altering the progression of damaged cells through the cell cycle. Therefore 
the accumulation of cells in any particular compartment of the cell cycle will 
not be observed instantaneously, but be dependant on the initial rate of cell 
cycling versus the extent of inhibition of cell cycling in the now damaged 
cells, hence the later sampling times.
5.9. Radiation induced p53 protein and cell cycle delay.
The lack of any radiation induced p53 protein in SV-HUC-1 cells was not 
unexpected due to the presence of the SV40 T-antigen and/or the mutant 
protein leading to the accumulation of high levels of non-functional p53. In 
addition there was an apparent corresponding absence of any radiation 
induced cell cycle delay, (neither Gi nor G2 /M  arrest) as measured by flow 
cytometry in SV-HUC-1 cells. Although this agrees with the previously 
reported observations of Maltzman and Czyzyk (1984), cell lines containing 
the T-antigen due to immortalisation by the SV40 virus are often more 
radioresistant than the corresponding non-immortalised cells from which 
they were derived (Arlett et al, 1988). In view of the proposed function of 
wild type or non-oncoprotein bound p53, i.e. as a specific transcriptional 
protein regulating down stream events that controls regulation of the cell 
cycle in response to DNA damage, it is difficult to reason why such cell lines 
would have an increased radioresistance conferred to them.
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The lack of any inducible p53 protein or cell cycle delay in T24 cells 
containing no viral sequences and normal levels of wt p53, may reflect 
differences between normal and cancer cell types even when mutant p53 
protein is not involved. Any protein which binds to wt p53 so abolishing its 
normal function could achieve this goal. Such a protein has recently been 
found in the form of the MDM2 protein reported in human sarcomas by 
Oliner et a l (1992). The examination of a greater number of such cell lines 
will provide more conclusive data.
The only cell line in this study which did show both a radiation induced 
p53 protein increase and a cell cycle delay was HPV. The increased level of 
wt p53 (approximately two fold) in HPV cells following irradiation was not 
as great as the 3-8 fold increase reported to occur at Gi arrest by Maltzman 
and Czyzyk (1984) and Kastan et al (1991). An increase in the G2 /M  
population and not Gl was observed with HPV cells following irradiation.
5.10. Possible controlling mechanisms of p53 and cell cycle delay.
It is possible that this G2 /M  delay is not directly caused by elevated p53 levels 
but as a consequence of a control mechanism affecting a number of other 
factors which act to delay the cell cycle not only at Gl but also at G2  following 
radiation induced DNA damage. Wt p53 protein may be expressed at an 
increased level, due to increased stabilization via phosphorylation events, 
interaction with other proteins or oligomerization (Lane and Crawford 1979, 
Finlay et al, 1998, Hupp et al, 1992). However, this protein must also be in 
an active form to achieve its regulatory function. A possible candidate for 
such a control mechanism are the changes in phosophorylation of p3 4 d^c2 
kinase which alters it's kinase activity, y irradiation of Chinese hamster 
ovary cells has been shown to cause a rapid inhibition of p3 4 cdc2  kinase
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activity and subsequent G2  arrest (Lock and Ross, 1990). The wild type p53 
protein is also affected by p3 4 d^c2  kinase acivity, becoming more 
phosphoryiated in S phase (Bischoff et al., 1992). Hence a reduction in p34 
<^ dc2 kinase activity in response to radiation damage would lead to a less 
phosphoryiated p53 protein molecule which in turn would inhibit 
progression of the cell into or through S-phase. Alternatively if such a 
pathway was no longer functioning then the same kinase also appears to 
have the ability to regulate cell cycling via a control mechanism acting at G2- 
(See Figures 5.13 and 5.14 for an overview of possible control mechanisms 
acting at Gi and G2  respectively). Finally it should be noted that this increase 
in p53 protein is reported to occur through a post transcriptional mechanism 
since mRNA levels do not change significantly following irradiation (Kastan 
et al., 1991). Also that the mechanism of control of this protein is probably 
not a simple one since it is acted upon by other kinases/ phosphatases such 
as protein phophatase 2A (PP 2A) which dephosphorylates p53 (Scheidtman 
et al, 1991).
5.11, To what extent can this model for p53 function be relied upon?
The overwhelming body of evidence now supports the theory of wt p53 as 
a tumour suppressor gene. The protein which is coded for by this gene, 
although not essential for development does appear to be needed to limit 
damage to the DNA and maintain tlie integrity of the genome. (Mice having 
no p53 genes develop normally but suffer from a high incidence of tumours 
in a variety of organs early in life, Donehower et al, 1992).
However, caution should be exercised when interpreting the data 
concerning DNA damage induced cell cycle delay, both in this study and 
others which have used flow cytometry to analyse such changes. Although
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FIG. 5.13. Gl
late group p53 bound to DNA at C-terminal 
domain resulting in transcriptional 
modification of downstream genes 
(possibly DNA polymerase a) so 
leading to arrest/inhibition of 
DNA synthesis.
p34odc2
+ve Active/functional kinase activity of 
p3 4 «ic2 phosphrylation of p53.
p53 nolonger binds to specific DNA sequences, no modification of downstream genes and progression through the cell cycle.
Mutant/SV40 bound p53 cannot act as a specific transcription factor/modulator.
Blocked by high levels of wt p53 when dephosphorylated i.e. bound to DNA
p53 highly phosphoryiated in S phase and not bound to DNA.
p34cdc2 also found in association with cyclin B as maturation promotion factor (MPF). Acts to delay mitosis by interaction with Histone HI (see Figure 5.13)
Adapted from Scheidtman et al., 1991 and Lane 1992b.
I N D U C T I O N  O F  p 5 3  1 1 3
Early G2
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FIG. 5.14. G
(pre PME)
- T v l P
INACTIVE
ACTIVE
MITOSIS
Maximally active state and entry into mitosis
Cyclin B
p34cdc2 kinase activity reduced - cell cycle blocked in G2. 
Perhaps due to phosphorylation status of Histone HI.
HI phosphorylated - dissociation with DNA- chromosome 
condensation and mitosis.
Adapted from Meek and Street 1992, Murray 1992.
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flow cytometry does provide a rapid means of measuring the cell cycle 
distribution of a large cell population, the distinction between a Gi arrest and 
inhibition of DNA synthesis may not always be clear. A Gi arrest implies 
that cells do not enter into S phase but accumulate in Gi, probably in 
response to DNA damage. Due to the technique of dual channel staining 
using an S-phase specific marker such as BrdU in flow cytometry, the GI, S 
and G2/M compartments of the cell cycle can easily be separated (Kastan et 
ah, 1991a, Kastan et ah, 1991b, Kastan et al., 1992, Kuberitz et al., 1992). Painter 
and Young (1980) reported that the cell cycle can in fact be halted by 
inhibition of replicon initiation within S phase following irradiation of 
human cells. If the cell cycle is perturbed in such a way then flow cytometry 
will not be able to distinguish between this S phase arrest and a Gi arrest. It 
will simply be manifested as a failure to take up the S phase specfic marker 
with a corresponding lack of FITC fluorescence.
Nethertheless, it is clear from the high incidence of p53 mutations or 
cellular alterations that act to abrogate wt p53 function, which are found in 
human cancer, that this gene plays a vital role in the development of many 
human neoplasias. The most likely mechanism for which is via a Gi or S 
phase arrest following DNA induced damage so allowing cellular repair 
processes time to rectify such damage before progression through the cell 
cycle.
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CHAPTER 6
GENERAL CONCLUSIONS
6.1 Cytogenetic responses to radiation.
Urinary epithelium immortalised by SV40 was approximately two fold 
more radioresistant in terms of the clastogenicity of radiation treatment than 
malignant cells from the same tissue. However, it is difficult to make any 
overall comparisons between SV40 immortalised cells and their normal 
counterparts from the same tissue type with the data available, T24 cells are 
not essentially normal because they were derived from a malignant source 
and only this one other cell line was available for study. A greater number 
of cell lines would need to be examined to make more general conclusions 
concerning the effects of the SV40 T-antigen on radiosensitivity with any 
great degree of certainty.
All SV40 immortalised human uroepithelial cell lines (SV-HUC-1, NTH 
and BC16) were derived from different transfection/infection experiments 
with the same individual's tissue and are not sub-clones from the same 
infection experiment. These cell lines exhibited quite marked differences in 
genomic stability as measured by spontaneous micronuclei frequencies, 
despite similar morphological appearances and cell cycling times. Therefore 
it is not solely the mere fact of the SV40 T-antigen within the a cell which 
leads to increased genomic instability but may also depend upon its site of 
integration, number of copies of the viral DNA sequence per host genome 
and secondary events following infection as an immortal clone is generated.
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6.2 Radiation induced p53 protein.
Induction of the nuclear phosphoprotein p53 following irradiation of 
human epithelial cells could only be detected in one of the cell lines studied;
HPV a human papilloma virus immortalised cell line (HPV) which exhibited 
an approximate two fold p53 induction above unirradiated cells. The study 
of cell cycle delay following irradiation where proposed DNA repair 
mechanisms gain an increased period for genomic repair revealed the 
following:-
No accumulation of any of the cell lines, SV40 immortalised, HPV and a 
malignant bladder carcinoma (T24), was observed in the Gi compartment.
Only cell line HPV exhibited any cell cycle delay which occured at the G2 /M  
border following irradiation. The reason for this G2 /M  delay may not in fact 
be due to p53 induction, since the p53 of HPV cells will be complexed with 
the E6 protein of human papilloma virus and hence probably already have 
usurped its wild type p53 function. However, another control mechanism 
which induces a number of proteins in response to genomic damage to allow 
prolonged cell cycling and extended DNA repair could have been activated,
A possible candidate for this is the p3 4 cdc2  complex (see section 5.10).
If mutant p53 is present or wild type p53 has had its function abrogated 
this then leads to greater genetic instability since p53 is acting as a "guardian 
of the genome" (Lane 1992b). Therefore cells having SV40 T-antigen which 
interferes with the normal function of p53 maybe expected to have altered 
genomic stabilities. This is reflected in the data presented in Figure 3.8 and 
discussed in section 6.1. Recently Lowe et al, 1993, Clarke et al, 1993 (and 
reviewed by Lane 1993) have shown that p53 is needed for radiation 
induced apoptosis. Thymocytes from null mice containing no p53 protein 
are 20 times more resistant to cell death as thymocytes containing two wild 
type alleles after irradiation. Cells which are heterozygous for p53 are 
intermediate in their response to radiation induced apoptosis. This provides
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support for the observation that SV40 immortalised cells (with altered p53 
function) were estimated to be approximately two fold more resistant to the 
lethal effects of gamma radiation than the bladder carcinoma cells T24 
(section 3.8)
The induced p53 radiation response of T24 cells is at first a little puzzling 
since they do not have any mutant p53 nor viral sequences that may act to 
abrogate its function, but T24 cells did not show an increase in the level of 
p53 protein following irradiation. From chapter 3 T24 cells have been shown 
to have a relatively high radiosensitivity and exhibit a high yield of 
micronuclei following radiation and cytokinesis blockage with cytochalasin 
B. Also from chapter 5 it can be seen that T24 cells do not display any 
significant cell cycle delay in Gi or G2 /M  following irradiation, which again
is unexpected given the p53 status of this cell line.
The above data could be accounted for if instead of the p53 status being 
changed, the proximal part(s) of the cell cycle delay were no longer 
functioning correctly, eg. If S of figure 6.1 was abrogated, and the sensory 
mechanism for detecting DNA damage which then leads to an increased 
stability of p53 protein was no longer functioning. This would result in no 
increase in the induced level of p53, no cell cycle delay and increased levels 
of DNA damage i.e. p53 function is altered because it is no longer able to be 
induced /  stabilised at the correct time, such as in response to genotoxic 
agents.
Further evidence for this type of mechanism as opposed to a DNA repair 
defect being the fault and accounting for increased radiosensitivity, could be 
to check for unscheduled DNA synthesis (UDS - DNA synthesis outside of 
S-phase). If the sensory mechanism(s) were no longer functioning correctly 
the UDS would still occur, although to a more limitted extent since there 
would be little cell cycle delay to permit increased DNA repair when 
compared to cells with a normal sensory mechanism and wild type p53
p53 inactive p53 active
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Gl Block/delay in cell cycle.
M
^ 0 2
Increased time for DNA repair.
DNA damage
Fig. 6.1 Possible defects in the p53 response to radiation 
of cell line T24. See text for details.
status. If however, the defect was due to a repair enzyme/complex
deficiency then UDS would not occur. Yet another approach to checking for
this idea of DNA repair defect v. a fault with sensing DNA damage and
relating this to p53 protein modulation, might be to use U. V. radiation as
opposed to gamma radiation. U.V. radiation is known to induce p53 and
cell cycle delay in normal mouse cells (Maltzman and Czyzyk 1984) but the
type of DNA lesion generated (largely thymidine dimers) requires different
repair enzyme complexes than those needed for gamma radiation induced
DNA damage. T24 cells are unlikely to be deficient in both types of repair
pathway and any lack of cell cycle delay/p53 induction would in that case
be due to an inability to sense/recognise such damage and couple this to cell
cycle delay.
Such approaches would not be without their problems, eg. different 
mechanisms may be responsible for sensing different types of DNA damage. 
However, it does give some suggestion of what future work in this area 
might perhaps try to elucidate i.e. the identification of other cellular 
components that interact directly or indirectly with p53 to mediate its 
function, such as the recently identified MDM2 gene product (Oliner et a l, 
1992).
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6.3 Radiation Induced Oncogenic Transformation.
Despite the genetic instability shown by two of the SV40 immortalised 
lines, such cell lines proved very resistant to full oncogenic transformation 
using a variety of different treatment protocols and culture regimes. Single 
and double radiation exposure experiments as well as maintaining cells as a 
confluent monolayer or continued passaging following carcinogen exposure 
all failed to produce such transformants. However, phenotypic alterations 
(morphological and decreased anchorage dependant growth) of human 
uroepithelial cells could be achieved when cells were maintained in a state of 
post confluent inhibited growth following both chemical and radiation 
carcinogen treatments. But, the progression from this "altered" phenotype 
to a tumourigenic one (i.e. tumour formation of inoculated cells in athymic 
mice) was not observed. From this it may be concluded that for SV40 
immortalised human uroepithelial cells a. cell culture conditions are of 
substantial importance in selecting for these phenotypically altered cells to 
be visualised b. Relatively infrequent events are probably required for the 
generation of a fully tumourigenic cell type from an "altered/initiated" 
phenotype in vitro, which by comparison occur with a much higher 
frequency.
This difficulty in obtaining fully oncogenic transformants when compared 
to the relative ease with which they are generated in rodent cell lines may 
reflect mechanistic differences in the progress of oncogenesis between 
human and rodent cells. Alternatively as suggested by Faber and Rubin 
1991, rodent cell lines may require as few as two events (genetic or 
otherwise, see section 1.4d) to generate neoplastic transformants, whereas 
human cells may require up to seven independent events to generate a 
similar phenotype.
G E N E R A L  C O N C L U S I O N S  1 2 0
Any data generated concerning radiation induced in vitro oncogenic 
transformation using either rodent cell lines or human cells immortalised 
with viral sequences must be treated with a degree of caution if direct 
comparisons/extrapolations are to be made to the in vivo human situation.
It is highly unlikely that neither of these two experimental systems exactly 
mimic tissues within the human body. However, we are faced with a 
dilemma, exposure limits, risk assessments etc... must be based on the data 
available. Rodents cells do not appear to make an accurate a model as 
human cells but even such human lines have been drastically altered by the 
viral sequences used to immortalise them when compared to normal human 
tissues. Although human kératinocytes have been reported to be capable of 
being maintained in culture using serum free medium with a mixture of 
growth factors and pituitary cell extract, similar reports with epithelial cells 
have not so far appeared. This problem will unfortunately remain unless 
alternative methods of immortalisation for human epithelial cells can be 
found.
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APPENDIX
OPTIMISATION OF CULTURE CONDITIONS AND 
GENERAL CHARCTERIZATION OF HUMAN
u roepithelial  CELLS m u c),
A.1 Culture media.
HUG lines have previously been grown in continuous culture since 1987 
by Dr. Catherine Reznikoff s group (Department of Human Oncology,
University of Madison, Wisconsin, USA). However, it was decided to assess 
the effect of different culture media on the growth/cell survival of HUC 
lines as measured by "grow back" assays since this data was not previously 
available.
Briefly; almost confluent cultures of SV-HUC-1 cells grown in Hams FI 2 
medium supplemented with 7% fetal calf serum (FCS) were dispersed using
0.1% EDTA for 20 mins at 37®C and 1x10  ^cells plated into 75 cm  ^tissue 
culture flasks with 10 mis of the appropriate medium. 48 hours after plating 
the medium was changed and then again a further 72 hours later. After at 
total of eight days incubation in the different media, cultures were harvested 
using 0.1% EDTA and cell counts obtained. All platings were done in 
triplicate. See Materials and Methods (section 2.1a ) for a detailed 
description of culture media and the supplements used.
Figure A.l shows the effect of the different culture media on cell growth 
for SV-HUC-1 cells. There is no significant difference between FI2 7%FCS,
F12+ 1%FCS (supplemented with Fe free human transferrin) and F12+ 1%
FCS (supplemented with Fe saturated human transferrin) in terms of 
differential growth rates. However, the growth of SV-HUC-1 cells was 
significantly reduced if cells were grown in either F12+ or FI2 alone (P- 0.05,
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student's f-test). Hence cells grew at an optimal rate in medium containing 
FCS even if this was reduced to 1%. FCS probably contains a growth factor 
that is not supplied by FI2 medium which is only required at a low 
concentration for the growth of SV-HUC-1 cells if other necessary growth 
supplements are also provided i.e. medium. Therefore the medium used 
to routinely grow HUC cells was F12+ 1%FCS (supplemented with Fe free 
human transferrin).
%
in
o)a
X(n
VMO
OJO
■  F12 7% F C S  
E3 F 1 2 + 1 % F C S  (F e f re e )
0  F I 2+ 1% FC S (F e  sa tu ra te d )  
0  F12+
□  F12
Medium Used.
FIG A .l Effect of different culture media on the growth of SV-HUC-1 
cells. Cells were harvested eight days after plating 1x10  ^cells (plating 
efficiency of approx 25% see table A.2). Error bars represent SEMs 
from triplicate platings.
A.2 Dispersal Methods.
A crutial procedure for the successful culture of any cell line which grows 
as an attached monolayer, is the ability to remove cells from the surface of a
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culture container and replate into a new flask/dish (passaging). If the 
viability of cells after such a procedure is greatly reduced, or only a small 
fraction of attached cells are removed, then maintaining such cells in culture 
will become increasingly difficult. Therefore different dispersal methods 
were assayed in order to elucidate the least toxic and most efficient removal 
conditions for HUC lines.
Briefly; 25 cm  ^culture flasks were seeded with 5x10  ^SV-HUC-1 cells after 
being removed using 0.1% EDTA for 20 mins at 37°C followed by tapping 
the flask (medium used was F12 7%FCS). After 4 days cultures were 
dispersed using the procedures outlined in table A.2. The "plating efficiency 
(F.E.)" data was calculated after replating 2.5 xlO  ^cells in 25 cm  ^flasks using 
F12 7% FCS medium. These cultures were left for a further 4 days 
(approximately two cell doublings, see section A.3) when the theoretical 
number of cells should be 1x10  ^if 100% plating efficiency. The F.E. values 
shown are expressed as a fraction of this figure, again cells were removed 
using 0.1% EDTA for 20 mins at 37°C followed by tapping the flask. "% cells 
removed" was calculated relative to certain trypsin treatments (*) for which 
the method of dispersal removed all attached cells. All cell counts were 
obtained using a haemocytometer
The collagenase treatments removed very few of the cells (less than 5% of 
the total number of cells in a flask). Therefore another flask could not be 
replated with 2.5 xlO  ^cells and accordingly a F.E. value has not been 
recorded. Shorter collagenase treatments (20 and 30 mins) removed even 
fewer cells, the data from which has not been shown. No single treatment 
produced a complete single cell suspension although that produced by 
EDTA coupled with trypsin treatment did produce the greatest number of 
single cells. Trypsin treatment alone greatly reduced cell viability even 
though a high proportion of attached cells were usually removed. When 
EDTA alone was used the plating efficiency varied between 18 and 27%. The
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use of EDTA coupled with trypsin treatment resulted in a cell suspension 
with the greatest viability. This method of cell dispersal/removal was 
routinely used to passage HUC cells.
A.3 Growth Kinetics of Epithelial Cell Lines.
The rate at which cells divide i.e the length of cell cycle, is of great 
importance when carrying out several assays utilized in this study such as 
the generation of binucleate cells for Mn analysis or the time taken for 
passaged cells to reach confluence in carcinogen treated cultures.
Briefly; 1x10  ^cells were plated in 25 cm  ^culture flasks in appropriate 
medium (see section A.la) which was changed every three days, harvested 
at 24 hours intervals and a cell counts taken. Table A.3 gives the cell 
doubling times in logarithmic phase of growth for the different epithelial 
lines used.
CELL LINE CELL DOUBLING TIME in 
logarithmic phase of growth (hours)
SV-HUC-1 42
NTH 39
BC16 43
T24 20
HPV 31
Table A.3 Cell doubling times for different human epithelial 
cell lines.
Cell cycling times for the SV40 immortalized lines (SV-HUC-1, NTH and 
BC16) were all similar (approximately 40 hours), where as that of the 
carcinoma cell line T24 was much shorter only 20 hours. The human 
papilloma virus transformed line HPV, had an intermediate cell cycling time 
of 31 hours. The cell cycling time for H Tori-3 cells was not determined
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because these cells were not used for any cell cycle dependant experiments, 
only for mutant or wild type p53 evaluation.
A.4 Chromosome Analysis
Cell line SV-HUC-1 had a range of chromosomes from 43 to 78 per scored 
metaphase. Within this spread of chromosome numbers there appeared to 
be two sub-populations, one being at or near diploid and the other exhibiting 
a highly aneuploid karyotype ranging in chromosome number from 62 to 78 
per scored metaphase (Figure A. 2)
No chromosome 15 was observed (Figure A. 3) this agrees with the data of 
Wu et a i, 1998 and Klingelhutz et al, 1991 who also reported no chromosome 
15 in some SV-HUC lines.
Number
of
metaphases
44 62 1 78
Chromosome number
Fig. A.2 Ploidy of SV-HUC-1 cells at passage 37.
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Cytogenetic responses of human uroepithelial cell lines and a 
malignant bladder carcinoma cell line to X-rays
M.P.Armitage, P.E.Bryant and A.C.Riches
Department of Biology and Preclinlcal Medicine, Bute Medical Building, 
University of St Andrews, St Andrews KYI6 9TS, UK
The responses to X-rays of three simian virus 40 (SV40) 
immortalized but non-tuniourigenic human bladder epithelial 
cell lines have been compared with a malignant bladder 
epithelial line using the micronucleus assay, A linear increase 
in induced micronuclei (MN) was observed for all four cell 
lines with increasing X-ray dose. The three SV40 immortal­
ized lines were found to be significantly less sensitive than 
the malignant cell line. Spontaneous levels of MN indicate 
that certain cell lines within the SV40 immortalized lines have 
a higher genetic instability. These cell lines may have a 
predisposition towards the generation of a fully transformed 
phenotype when treated with carcinogenic agents.
Introduction
Present knowledge concerning radiation induced neoplastic 
transformation in vitro has relied heavily on the use of rodent 
embryonic fibroblast cell lines such as C3H10T16 (Terzaghi and 
Little, 1976; Elkind et a l. , 1985; Hall and Hei, 1986; Hei et al. , 
1988). The responses of rodent cell lines although useful, 
probably cannot be directly compared to that o f human cells due 
to interspecies differences (Reznikoff et a l ,  1986). Moreover, 
the majority of human cancers (>80% ) originate in epithelial 
cells (Cairns, 1975). Thus fibroblastic lines may not represent 
an appropriate model for human carcinogenesis.
Christian et al. (1987) have reported the use of human 
uroepithelial cell lines (SV-HUC) immortalized with simian virus 
40 (SV40) as a possible model system for studying the oncogenic 
effect of chemical carcinogens. The use of the chemical 
3-methylcholanthrene on a non-tumourigenic but immortal 
SV-HUC line resulted in transformation to a fully neoplastic 
phenotype (Reznikoff et a l ,  1988).
In this paper we present data on the clastogenic response to 
radiation of three such SV-HUC lines as a prelude to an investiga­
tion of the carcinogenic response of these lines to ionizing 
radiation. Due to the difficulty in obtaining viable single cell 
suspensions the use of clonal assays proved an unreliable measure 
of radiation response when assayed by cell survival in SV-HUC 
lines. The clastogenic response of these cells was therefore chosen 
as an alternative to a clonal assay as a way of assessing their 
radiosensitivity. The clastogenic effect o f X-rays has been 
measured in these cell lines using the cytokinesis-block technique 
of Fenech and Morley (1985). The cytogenetic response of these 
SV-HUC lines has been compaied with that of a urothelial 
carcinoma line (T24) for which we were able to obtain a survival 
curve using a clonogenic assay.
Materials and methods
Cell culture
SV-HUC lines were derived by Dr C.A.Reznikoff using SV40 to infect human 
ureteral explant tissue. This gave rise to a number of immortalized but non- 
tumourigenic clonogenic cell lines (Christian et al., 1987). SV-HUC lines
©  Oxford University Press
(designated SV-HUC 1, NTH and BC16) were cultured in Hams F12 medium 
(Gibco) supplemented with 7% fetal bovine semm (FBS; Globepharm), penicillin 
100 units/ml (Glaxo) and streptomycin 100 /^g/ml (Evans). Cultures were 
maintained at 37°C in an atmosphere of 5% CO  ^ in air using 75 cm  ^ culture 
Basks. Cell densities ranged from ~ 4  x  10^  cells/flask when initially seeded 
into a flask to 7 x  10^  cells/flask at confluence. Medium was changed every 
2 —3 days. Removal of cells from flasks for routine passaging was achieved using 
0.1% ethylenediamine tetraacetic acid (EDTA; Sigma) in Hanks’ balanced salts 
solution. When just subconfluent, cells were removed from the flasks surface 
with EDTA and seeded in 25 cn f flasks at a density of ~  1.5 x  10^  cells/flask. 
These cultures were incubated for -  1 week until cells were in mid-exponential 
phase of growth before irradiation.
Bladder carcinoma cells used were MGH-Ul and have actually been shown 
to be T24 cells by DNA fingerprinting tests (Masters et al., 1988). These cells 
were cultured in a similar way except the medium used was RPMI (Northumbria 
Biologicals Ltd) supplemented with 5% FBS, antibiotics and L-glutamine 2.0 inM 
(Flow Laboratories). Cells were removed from flasks using 0.01 % recrystalliz­
ed trypsin (Cooper Biomedical) with 0.2% EDTA in phosphate-buffered saline 
(PBS). Cultures were again passaged just prior to confluence, replated at 1 X 
10^  cells/flask in 25 cm flasks and incubated for 3 —4 days before irradiation, 
again in mid-exponential phase of growth.
Passage numbers used were: SV-HUC 1: P32—P36; NTH: P20—P25; BC16: 
P28—P31. The passage number of T24 cells is unknown.
Colony assays after X-ray treatment of T24 cells were carried out in 90 mm 
plastic petri dishes. The number of cells plated was adjusted so that 100—200 
colonies per dish would result after a 6 day incubation period. Dishes were then 
fixed in methanol for 10 min, stained in 10% Giemsa in water for 10 min and 
rinsed in water. Colonies of > 50  cells were scored.
X-irradiatlon
Cells were irradiated whilst attached to flasks. Cells were given various doses 
of 250 kv (0.5 mm Cu) X-rays. The dose rate was 0.74 Gy/min. Doses were 
checked using a ferrous sulphate technique (Frankenburg, 1969). 
Micromcleus assay
Micronulei (MN) were assayed using the cytokinesis block technique. The method 
was essentially that of Fenech and Morley (1985). Briefly, immediately after 
irradiation cytochalasin B (Cyto B; Sigma; stock solution 3 mg/ml in DMSO) 
was added to give a final concentration of 3 ftg/ml. Cultures were then incubated 
for a 48 h before harvesting with EDTA or trypsin.
Preparation o f  slides
Slides were prepared by centrifugation using a Shandon Cytospin 2 (800 r.p.m. 
for 10 min) and fixed in methanol (10 min). Slides were then stained in 56% 
Jenners in water for 5 min, rinsed in water, 25% Giemsa in water for 10 min 
and again rinsed in water. Acridine Orange staining was performed on some slides 
using the method described by Tinwell and Ashby (1989) after destaining 
Jenner/Giemsa stained slides in methanol:acetic acid (3:1) overnight. Fluorescence 
microscopy was performed using 450—490 nm wavelength light. A total of 200 
binucleate cells were scored per sample per experiment.
Imniimocytochemical staining fo r SV40 T-antigen
Cells were grown overnight on glass slides in a humidified incubator in a 5% 
CO2 in air atmosphere. Slides were then washed in PBS, fixed in ice cold 
acetone:methanol Ô :3) and rehydrated in PBS containing 1 % sheep serum (1 % 
SSPBS), 37°C for 30 min. Mouse antiserum antibodies (IgGj) prepared against 
SV40 T-antigen was diluted 1:25 in 1 % SSPBS and added to the fixed cells which 
were then incubated for 1 h as above. (Cells incubated in 1 % SSPBS without 
tlie primary antibody served as a negative control.) After rinsing in PBS to remove 
the primary antibody, HRP-conjugated sheep antimouse IgG antibodies diluted 
1:20 in 1 % SSPBS were added and incubated for a further 1 h. Following rinses 
in PBS and staining in 3,3'-diamino benzidine tetrahydrochloride (DAB; Sigma) 
for 5 min, cells were finally counter stained in haematoxylin, dehydrated and 
clear mounted.
Results
In multiple sampling experiments (Figure 1) we investigated the 
influence of harvest time on MN formation in Cyto B blocked
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Fig. 1. Frequency of MN in binucleate cells as a function of time following 
X-irradiation (4.0 G), Error bars represent standard errors of mean (SEM) 
values from two separate experiments.
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Fig. 3. Binucleate cell index (frequency of binucleate cells/total number of 
cells) as a function of sampling time following irradiation (4.0 G). Error 
bars represent mean values from two experiments.
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Fig. 2. Dose—response relationship between frequency of MN and X-ray 
dose. Sampling time was 48 h after irradiation. Error bars represent SEM 
values from at least three separate experiments. (Background MN values 
have been subtracted from the data shown.)
irradiated cells. These results showed that there is no definite 
peak in MN response at a given harvest time, but that the MN 
frequency increases steadily with sampling time and appeared 
to plateau in the cell line N TH . NTH cells were found to be 
considerably less sensitive than the bladder carcinoma line (T24) 
in terms of its MN response to X-rays at comparable harvest 
times. This is also demonstrated by the X-ray dose—response 
curve obtained at a fixed harvest time of 48 h (Figure 2). The 
three SV-HUC lines showed similar dose—response curves to 
one another. These lines were much less steep than that of the 
T24 line. At 6 Gy there was a significant difference between the 
MN response of SV-HUC 1 and that of cell line T24 o f f  <  0.01, 
Student’s Mest. All four lines showed a linear increase in 
frequency of induced MN with X-ray dose for the 48 h sampl­
ing time.
co
u2
O)c
’>
.001
Fig. 4. Cell survival curve for cell line T24. Error bars represent SEM 
values from at least three separate experiments. The dotted line indicates the 
approximate survival curve for SV-HUC lines.
Although the cell cycling times of the cell lines in exponential 
growth were found to be —39, 42, 43 and 20 h for cell lines 
NTl 1, SV-HUC 1, BC16 and T24, respectively (data not shown), 
48 h harvest time in multiple sampling time experiments was 
found to be an optimal sampling time. At sampling times later 
than 48 h the frequency of binucleate cells (binucleate cell index) 
fell to levels which made accurate scoring of MN very difficult. 
Figure 3 shows that the maximum binucleate index occurred at 
—48 h for the cell lines N TH  and T24.
The survival curve of T24 cells to X-rays (Figure 4) gave a 
point of reference for a comparison with the MN dose—response 
curves. SV-HUC lines would be expected to show increased 
survival to X-rays when compared to T24 cells and is indicated 
by the dotted line.
The spontaneous level o f MN after Cyto B blockage alone 
(Figure 5) was found to be high for cell lines SV-HUC 1 and 
N Tl 1 but low for BC16 and T24. The difference between BC16
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Fig. 5, Spontaneous frequencies of MN in binucleate cells 48 h after 
addition of cytochalasin B. Error bars represent SEM values from at least 
three separate experiments.
Fig. 6. Acridine Orange fluorescence of binucleated NTH cells 48 h after 
4.0 Gy of X-rays and cytokinesis blockage with cytochalasin. Several MN 
per cell are shown and the boundaries of cell cytoplasm can clearly be 
distinguished. The bar represents 10 /mi.
and both SV-HUC 1 and NTH was significant {P <  0.05), 
Student’s Mest. The spontaneous MN level observed for cell lines 
BC16 and T24 fall within the range of values observed for other 
human cells such as lymphocytes; 4.0 — 67.3 MN/1000 
binucleated cells (Fenech et al., 1990).
Acridine Orange staining was performed on selected slides to 
check for possible artifacts resulting from the Jenner/Giemsa 
staining. Cytospinning when coupled with Jenner/Giemsa staining 
gave a very gtxxl contrast between cytoplasm (blue) and the nuclei 
or MN (mauve). Another advantage of this method was that the 
distribution of cells on the slide was predictably in one area with 
cells in relatively close proximity. Thus, boundaries of cell 
cytoplasm could be easily identified. These factors allowed 
accurate scoring of slides much more rapidly than with standard 
spreading techniques. The staining with Acridine Orange (Figure
6) indicated that the MN produced are nuclear fragments and 
not artifacts of the Jenner/Giemsa stain.
Immunocytochemical staining for SV40 T-antigen DNA was 
positive for the SV-HUC lines but no staining was observed with 
the malignant bladder cell line T24.
Discussion
From Figure 1 it can be seen that the frequency of MN increased 
with time following irradiation. The results show that the SV- 
HUC lines all had similar chromosomal radiosensitivities as 
estimated from MN frequencies at 48 h following X-irradiation 
(Figure 2). Data shown in Figures 1 and 2 indicates that these 
SV-HUC lines were significantly less radiosensitive than the T24 
cell line (also of bladder epithelial oigin). It is possible that the 
apparent relative radiosensitivity of T24 cells could be influenced 
by the shorter doubling time of T24 relative to the SV-HUC lines. 
This will lead to the more rapid accumulation of MN with time, 
as seen in Figure 1 and as discussed by Savage (1989). This effect 
may however to some extent be offset by the more rapid exit 
of T24 cells from the binucleate into the quadranucleate 
compartment (unscored cells) as shown in Figure 3. 
Tumourigenic T24 cells are themselves reported to be somewhat 
radioresistant when compared with certain other tumour cell lines 
(Parris et al. , 1988). The expression of the SV40 T-antigen within 
human fibroblasts has also been shown to decrease radiosensitivity 
(Arlett et al. , 1988). SV-HUC lines have been immortalized but 
are not fully transformed. However, they do contain the SV40 
T-antigen (Christian et al., 1987) and immunocytochemical 
staining in our laboratory. This lack of a fully transformed 
phenotype but presence of the SV40 T-antigen supports the idea 
that it is this sequence of viral DNA that somehow confers in­
creased radioresistance to the cell.
Due to the difficulty in obtaining a viable single cell suspension 
of the SV-HUC lines colony assays could not be used to determine 
survival curves. However, the MN freuqencies as shown in 
Figure 2 indicates an almost 2-fold lower induction of MN in 
SV-HUC lines than in T24 cells. Because of the radioresistant 
nature of the SV-HUC lines in terms of X-ray induced MN levels, 
a probable survival curve for the three SV-HUC lines is shown 
by the dotted line in Figure 4. This approximate survival curve 
is based on the MN data and makes the assumption that most 
X-ray induced MN will be lethal events.
The spontaneous or background level of MN in binucleated 
cells (Figure 5) gives an indication of the genetic stability for 
each cell line. Cytogenetic instability has already been reported 
in cell line SV-HUC I by Meisner et al. (1988). Cell line N T H , 
having an even higher spontaneous MN value than cell line 
SV-HUC 1, suggests that NTH cells have a greater genetic 
instability than the other SV-HUC lines.
Whereas X-ray induced MN are known to be composed almost 
entirely of acentric fragments (Thomson and Perry, 1988; 
Littlefield et a l. , 1989) it is not known if these spontaneous MN 
are the result of acentric fragment formation or whole 
chromosome loss. However, work by Meisner et al. (1988) on 
cell line SV-HUC 1 shows that this genetic instability resulted 
in chromosomal loss and duplications coupled with translocations 
and reduction in polyploidy as passage number increased. These 
spontaneous genetic changes alone did not result in the generation 
of a tumourigenic phenotype.
The genetic instability shown by two of the SV-HUC lines may 
allow a synergistic effect between this instability and other 
additional genetic changes such as oncogene activation or tumour
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suppressor gene loss, both of which are known to occur by the 
types of genomic rearrangements mentioned above. These 
additional changes may be necessary stages in the multistep 
process of carcinogenesis. Transformation experiments using the 
SV-HUC lines exposed to X-rays are under way in our 
laboratory.
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